Risk assessment and risk management of novel plant foods:Concepts and principles by Knudsen, Ib et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
Risk assessment and risk management of novel plant foods
Concepts and principles
Knudsen, Ib; Søborg, Inge; Eriksen, Folmer Damsted; Pilegaard, Kirsten; Pedersen, Jan W.
Publication date:
2005
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Knudsen, I., Søborg, I., Eriksen, F. D., Pilegaard, K., & Pedersen, J. W. (2005). Risk assessment and risk
management of novel plant foods: Concepts and principles. Copenhagen, Denmark: Nordic Council of Ministers.
(TemaNord; No. 2005:588).
 

Risk assessment and risk 
management of novel plant 
foods  
Concepts and principles 
 
Ib Knudsen, Inge Søborg, Folmer Eriksen, Kirsten Pilegaard and 
Jan Pedersen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TemaNord   2005:588  
 Risk assessment and risk management of novel plant foods  
Concepts and principles 
 
 TemaNord  2005:588  
© Nordic Council of Ministers, Copenhagen 2005 
ISBN 92-893-1251-3 
Print:  Ekspressen Tryk & Kopicenter 
Cover photo: Dr. Michael Hermann 
Copies: 400 
Printed on environmentally friendly paper  
This publication can be ordered on www.norden.org/order. Other Nordic publications are available 
at www.norden.org/publications 
 
Printed in Denmark 
 
 
Nordic Council of Ministers Nordic Council  
Store Strandstræde 18 Store Strandstræde 18 
DK-1255 Copenhagen K DK-1255 Copenhagen K 
Phone (+45) 3396 0200 Phone (+45) 3396 0400  
Fax (+45) 3396 0202 Fax (+45) 3311 1870 
 
www.norden.org 
 
 
 
 
 
 
 
 
 
 
 
Det nordiske levnedsmiddelsamarbejde 
Nordisk Embedsmandskomité for Levnedsmiddelspørgsmål (EK-LIVS) arbejder med principielle 
levnedsmiddelpolitiske spørgsmål vedrørende kost og ernæring, levnedsmiddeltoksikologi og -
mikrobiologi bl.a. i relation til risikovurdering, levnedsmiddelkontrol og -lovgivning. Samarbejdet 
sigter på beskyttelse af forbrugernes sundhed, fælles udnyttelse af faglige og administrative ressour-
cer samt nordisk og international udvikling af fagområderne.  
Nordic co-operation  
Nordic co-operation, one of the oldest and most wide-ranging regional partnerships in the world, 
involves Denmark, Finland, Iceland, Norway, Sweden, the Faroe Islands, Greenland and Åland. Co-
operation reinforces the sense of Nordic community while respecting national differences and simi-
larities, makes it possible to uphold Nordic interests in the world at large and promotes positive 
relations between neighbouring peoples. 
Co-operation was formalised in 1952 when the Nordic Council was set up as a forum for parlia-
mentarians and governments. The Helsinki Treaty of 1962 has formed the framework for Nordic 
partnership ever since. The Nordic Council of Ministers was set up in 1971 as the formal forum for 
co-operation between the governments of the Nordic countries and the political leadership of the 
autonomous areas, i.e. the Faroe Islands, Greenland and Åland.  
  
Contents 
Definition of terms used in this report ........................................................................ 11 
Summary .................................................................................................................... 13 
Dansk resumé ............................................................................................................. 17 
Yhteenveto ................................................................................................................. 19 
1. Introduction ............................................................................................................ 23 
2. Regulations (EU and worldwide) ..................................................................... 25 
2.1 The European Union................................................................................. 25 
2.1.1 United Kingdom .................................................................................... 26 
2.2 Canada............................................................................................................ 27 
2.3 Australia/New Zealand................................................................................... 30 
2.4 Conclusions on regulations............................................................................. 31 
3. Historical experience .............................................................................................. 33 
3.1 Food plants and food plant toxins................................................................... 33 
3.2 The Age of Exploration.................................................................................. 34 
3.3 Before the EU regulation................................................................................ 35 
3.4 After the EU regulation .................................................................................. 35 
3.5 Conclusions on historical experience ............................................................. 36 
4. Examples – past and present................................................................................... 37 
4.1 Rapeseed ........................................................................................................ 37 
4.2 Lupin seed ...................................................................................................... 38 
4.3 Kiwi fruit........................................................................................................ 41 
4.4 Red kidney bean ............................................................................................. 42 
4.5 Carambole (star fruit) ..................................................................................... 43 
4.6 Nangai or ngali nut ......................................................................................... 44 
4.7 Noni Juice....................................................................................................... 46 
4.8 Cassava (Manihot esculenta Crantz) .............................................................. 47 
4.9 Conclusions on experiences from past and present cases ............................... 48 
5. Potential for new, novel plant foods to be introduced on the EU market................ 51 
5.1 Conclusions on the potential for novel plant foods  to be introduced in  
Europe............................................................................................................ 53 
6. Assessment of novelty and safety of plant foods. ................................................... 55 
6.1 Determination of novelty of the plant food as part of the establishment 
 of a risk profile.............................................................................................. 56 
6.2 Establishment of a risk assessment policy for conduct of the scientific risk 
assessment...................................................................................................... 60 
6.3 Conclusions on the assessment of novelty and safety..................................... 64 
7. Different tools applicable for premarket analysis ................................................... 65 
7.1 Characterisation of a plant food...................................................................... 66 
7.1.1 Botanical characterisation ..................................................................... 66 
7.1.2 Chemical characterisation ..................................................................... 67 
7.2 History of use as food..................................................................................... 70 
7.3 Animal studies in the safety testing of novel plant foods ............................... 73 
7.4 Testing of novel foods in in vitro tests for toxicity and mutagenicity ............ 75 
7.5 Test of novel foods for allergenicity............................................................... 76 
7.6 New ”omics” methods.................................................................................... 77 
7.7 Human data .................................................................................................... 78 
7.8 Nutritional aspects.......................................................................................... 79 
7.9 Exposure assessment ...................................................................................... 79 
7.10 Risk characterization and safety ................................................................... 80 
7.11Conclusions on tools applicable for premarket analysis ................................ 81 
6 Risk Assessment and Risk Management of novel Foods 
8. A plea for a continued interactive exchange of concepts and ideas between 
 management and science in this field .................................................................... 83 
9. Overall conclusions and recommendations. ........................................................... 91 
10. References............................................................................................................ 95 
Annex 1. Examples of NUS in the Regions ............................................................. 100 
Annex 2. Draft global list based on the FAO-list of global plant food production... 103 
Annex 3. Draft regional plant list based on the NETTOX food plant list. ............... 106
 
 
  
Preface  
The Nordic Committee of Senior Officials for Food Issues is a body un-
der the Nordic Council of Ministers co-ordinating Nordic work in the 
field of foods. The Nordic Working Group on Food Toxicology and Risk 
Evaluation (NNT) has been given the responsibility by the Committee to 
promote co-operation and co-ordination among Nordic countries in mat-
ters relating to food toxicology and risk assessment. 
Under this working group a project group was funded and established 
with the aim to discuss different aspects of defining, regulating and 
evaluating whole foods derived from plants with no or limited docu-
mented history of safe consumption and to propose a strategy for the 
safety assessment of these foods. This work was originally proposed to be 
part of the OECD Task Force Group for the Safety of Novel Foods and 
Feeds, with the Nordic project group as the leading “country”. The 
OECD Task Force Group decided not to take this work into its work pro-
gramme for the moment but use the final Nordic report for its decision on 
future activities in this area in the Task Force Group.  
 
The project group consisted of the following members: 
 
Jan Pedersen 
 (Chairman) 
Danish Institute for Food and 
Veterinary Research 
Denmark 
Ib Knudsen Danish Institute for Food and 
Veterinary Research 
Denmark 
Folmer D. Eriksen Danish Institute for Food and 
Veterinary Research 
Denmark 
Inge Søborg Danish Institute for Food and 
Veterinary Research 
Denmark 
Leena Mannonen Ministry of Trade and Industry Finland 
Christer Andersson National Food Administration Sweden
Arne Mikalsen Norwegian Scientific  
Committee for Food Safety 
Norway 
 
The report has been compiled and prepared by Ib Knudsen, Inge Søborg, 
Folmer Eriksen, Kirsten Pilegaard and Jan Pedersen.   
In order to bring in a worldwide perspective on the subject an interna-
tional workshop was arranged to discuss a draft report. This Workshop 
was held in Copenhagen 18-19 May 2005. The participants in the work-
shop were all invited to present their background and personal view on 
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the situation and bring useful information and new ideas to the Nordic 
project group.  
 
Invited persons for the workshop: 
 
Nora Lee Health Canada Canada 
Leanne Laajoki Food Standards Australia 
New Zealand (FSANZ) 
Australia 
Marten Sørensen The Royal Veterinary and 
Agricultural University 
Denmark 
Kirsten Pilegaard Institute for Food and  
Veterinary Research 
Denmark 
Jørn Gry Institute for Food and  
Veterinary Research 
Denmark 
Morten Poulsen Institute for Food and  
Veterinary Research 
Denmark 
Heddie Mejborn Institute for Food and  
Veterinary Research 
Denmark 
Hanne Boskov  
Hansen 
Danish Veterinary and Food 
Administration 
Denmark 
Jiri Ruprich National Institute of Public 
Health 
Czech Republic 
Michael Hermann IPGRI-Colombia Colombia 
Mar Gonzalez OECD, Environment  
Directorate 
France 
Päivi Mannerkorpi DG SANCO Belgium 
Karl-Heinz Engel EFSA Italy 
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Samuel W. Page WHO Switzerland 
 
 
NNT is responsible for the text of the report and its conclusions and rec-
ommendations.  
 
The report has been reviewed and accepted by NNT in September 2005. 

 Definition of terms used in this 
report 
• Foods: Foods and food ingredients. 
• Plants: Conventional plants meaning cultivated plants without use of 
gene technology, and plants from wild sources.  
• Plant foods: Products used as food with a plurality of chemical 
constituents in a complex, holistic interplay ranging from intact fruits 
and vegetables, over complex botanical products like flour and 
botanical extracts to oils, fibres and proteins. Distinct from pure 
chemicals with only one chemical entity as the building block. 
• Traditional foods: Foods with a history of significant human 
consumption by the broad community for several generations as part 
of the ordinary diet and thereby generally recognised as safe at the 
global, regional or local level or by an ethnic group. 
• Non-traditional foods: Foods with no history of significant human 
consumption by the broad community for several generations as part 
of the ordinary diet. 
• Novel foods: Non-traditional foods for which there is insufficient 
knowledge in the broad community to ensure safe use, or which have 
characteristics that raise safety concerns due to composition, levels of 
undesirable substances, potential for adverse effects, traditional 
preparation and cooking, and patterns and levels of consumption. 
• Global list of traditional food plants: A list of plants, identifiable by 
name and delivering specified plant material used for traditional foods 
at the global level.  
• Regional lists of traditional food plants: A set of lists with plants 
delivering plant material used for traditional foods at the regional level 
covered by the individual list. “The Region” may be defined on the 
basis of the five regional dietary patterns described by WHO/FAO in 
GEMS (WHO, 2003): Middle Eastern, Far Eastern, African, Latin 
American and European (incl. Australia, Canada and the USA), or as 
economical or regulatory entities like EU or Australia/New Zealand. 
When finalised the lists should cover all geographical regions of the 
world, thereby supplementing each other. 
• Local lists of traditional food plants: Lists with plants delivering plant 
material used for traditional foods at the local level. A “Local lists” 
could cover EU, or individual nations like Denmark and China, or an 
area with a human population of mixed ethnic origin within a region 
or nation.  
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• Ethnobotanical lists of traditional food plants: Individual lists with 
plants delivering plant material used for traditional foods by 
individual ethnical groups. “Ethnobotanical lists” are lists developed 
to cover well established plant food eating habits of a defined ethnic 
entity, e.g. aboriginals in Australia.   
• History of use: Relevant data for history of use is characterisation of 
the plant species and composition of the food item, collection of 
information regarding historical evidence for food use, possible 
adverse effects as well as other characteristic effects in humans, 
cultivation/harvesting, processing and preparation methods, amount to 
be eaten. 
• History of safe use for a food: Term used for the qualified 
presumption of safety making the food generally recognised as safe in 
the community. The evidence for safety of the food derives from 
compositional data and from experience since the food has been an 
ongoing part of the diet for a number of generations in a large, 
genetically diverse population in that community. This presumption is 
for a certain context of use (conditions of use, defined part of the plant 
used and required processing) and allows for minor population 
predispositions such as intolerance and allergenicity.  
 Summary 
Around 30 food plants deliver 95% of human daily intake of plant food 
calories on a worldwide basis. In Europe the last 5 percentages of the 
daily plant food calory intake, herbs, etc. is delivered by roughly 300 
other plant species. Both the 30 and the 300 plants have the potential to 
deliver novel food items from plant parts which not hitherto have been 
used in the human food supply but the major potential source for novel 
plant foods is the nearly 7000 other plant species traditionally used in the 
human food supply in other parts of the world. This report focuses on the 
situation when novel food items from these 7000 plants are to enter the 
European market.  
The historical experience as well as experiences from past and present 
introductions of new plant foods in Europe like rapeseed, lupin seed, kiwi 
fruit, red kidney bean, carambole, nangai nut, noni juice and cassava are 
analysed with the conclusion that some novel plant foods, like cassava, 
may need special attention when introduced in countries and regions, 
where there is no tradition for their use. 
The report takes its starting point in the novel food regulation already 
in force in the European Communities, Australia/New Zealand and Can-
ada. The legislation in all three places distinguishes between the tradi-
tional plant foods on one side and the novel plant foods on the other side 
because the novel plant foods need to go through a premarket assessment 
procedure. Since this regulation is pretty new, the EU legislation from 
1997, the managerial and scientific instruments for the enforcement of 
this regulation are still under development. 
On this background the present report has developed a proposal for a 
set of definitions and criteria for determining if a plant food is traditional 
or novel and a proposal for an approach for the safety assessment of such 
plant foods with no or limited documented history of safe consumption.  
 
The Nordic Working Group recommends to introduce: 
 
• The use of a 2-step management procedure, first to establish the 
novelty and secondly to define and commit resources for the safety 
assessment, and  
• The use of a worldwide net of global, regional, local and 
ethnobotanical positive lists for food plants to guide the decision on 
novelty at the first step and to enable the safety assessment at the 
second step. 
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At the first step of the 2-step management procedure the management 
should establish a risk profile with the input from stakeholders, scientists 
in the field and consumer representatives taking into account the product 
itself, information on expected intake, history of use, values at risk, e.g. 
human health, economy, other potential consequences, consumer percep-
tion of risks and benefits, and societal distribution of risks and benefits. 
The plant lists discussed below are an integrated element of the history of 
use. The discussions at this step should lead to the conclusion whether the 
plant food under consideration is traditional at the regional level or local 
level or a traditional ethnic food in the area, or actually a novel plant 
food, which needs a safety assessment according to the regulation.  
At the second step of the 2-step management procedure the manage-
ment decides on a general risk assessment policy for all plant foods de-
fined as novel foods at the first step. The risk assessment policy defines 
the extent and sequence of the scientific data, which should be made avai-
lable for the scientific risk assessors for the premarket assessment. 
For a smooth introduction of the so-called exotic fruits and vegetables 
from one region to another the NNT recommends to use the “history of 
use”-concept as the core ingredient of the premarket submission. To the 
extent that the data submitted by the applicant can support the claim that 
a product has a history of safe use, the submission can be approved. 
To support and ease the availability of a high quality “history of use” 
data set for the premarket submissions the NNT recommends the devel-
opment of a worldwide net of positive lists of food plants recognizing the 
plants as sources of foods either at the global level, at different regional 
levels or local levels or known as ethnobotanical foods in different 
places. The individual lists should reflect the use of plant foods in the 
region, at the local level or the ethnobotanical setting, where they are 
developed. When all of them are available, they should create a complete 
worldwide picture of the use of plant foods. The expectation of the NNT 
is that the combined use of data from all these lists will facilitate the mu-
tual acceptance of safety and benefits of plant foods and plant food ingre-
dients across political, economical and cultural borders. The NNT rec-
ommends that all lists should be developed after the internationally 
agreed principles and build on the internationally agreed criteria to be-
come mutually acceptable, e.g. in WTO, and stresses that all the lists 
should be based upon reliable, high quality information and proper refer-
ence sources in order to meet the acceptance of critical scientific asses-
sors. 
The report gives recommendations in an area of the food safety arena, 
where there is still very little scientific experience. All concepts are very 
new, and the principles are not fixed by regulatory traditions yet. There-
fore the NNT strongly recommends continued interactive exchanges of 
concepts and ideas between management and science in this field both 
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horizontally and vertically to ensure that the best legal and scientific in-
struments for the work will be chosen. 

 Dansk resumé 
Omkring 30 fødevareplanter bidrager med ca. 95% af det daglige kalorie 
indtag fra planter på verdens basis. I Europa kommer de sidste 5% af 
kalorie indtaget rundt regnet fra 300 andre planter. Både de 30 og de 300 
planter har potentialet til at levere nye fødevarer fra plantedele der ikke 
hidtil har været anvendt til fødevarer, men det største potentiale, som 
kilde til nye fødevareplanter, er de omkring 7000 andre plantearter der 
anvendes andre steder i verden som fødevarer. Denne rapport fokuserer 
på den situation hvor nye fødevareprodukter fra disse ca. 7000 plantearter 
er på vej til det Europæiske marked. 
Den historiske og nuværende erfaring med introduktion af nye plante-
fødevarer i Europa som f.eks. raps, lupinfrø, kiwi, rød have-bønne, stjer-
nefrugt, nangai nød, noni juice og cassava bliver analyseret med den kon-
klusion at nogle nye plantefødevarer som f.eks. cassava (maniok) bør 
have speciel opmærksomhed når de introduceres i lande eller regioner 
hvor der ikke er tradition for deres anvendelse. 
Rapporten tager udgangspunkt i de reguleringer af nye fødevarer som 
findes i EU, Australien/New Zealand og Canada. Lovgivningerne skelner 
alle tre steder mellem traditionelle fødevarer på den ene side og nye fø-
devarer på den anden side, hvor de nye fødevarer skal gennemgå en vur-
dering før de kan markedsføres. Fordi disse reguleringer er forholdsvise 
nye (EU reguleringen er fra 1997) er både de administrative og videnska-
belige redskaber stadig under udvikling.  
På denne baggrund leverer denne rapport forslag til definitioner og 
kriterier for bestemmelse om en fødevareplante er traditionel eller ny og 
foreslår en arbejdsmetode for den faglige risikovurdering af nye plantefø-
devarer hvor der er begrænsede eller ingen erfaring med deres anvendelse 
som fødevare. 
 
Den Nordiske Arbejdsgruppe anbefaler at introducere: 
• En 2 trins håndteringsprocedure, hvor der først tages stilling til om 
produktet et nyt eller traditionelt og derefter definerer behovet og 
omfanget af den faglige risikovurdering. 
• Brugen af et verdensomspændende net af globale, regionale, lokale og 
etnobotaniske positiv lister med fødevareplanter til brug for 
beslutningen i første trin om et produkt er nyt og til at fastlægge 
behovet for og hjælpe til den faglige risikovurdering i andet trin. 
 
I det første trin af 2-trins håndteringsproceduren bør der etableres en risi-
ko profil med input fra interessenter, fagfolk på området og forbruger 
repræsentanter med hensyntagen til selve produktet, forventet størrelse af 
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indtag, history of use (erfaringer med anvendelsen), værdier på spil f.eks. 
sundhed, økonomi og andre potentielle konsekvenser, forbrugernes opfat-
telse af risiko og fordele samt den sociale fordeling af risiko og fordele. 
De plantelister der diskuteres nedenfor er en integreret del af history of 
use. På dette trin bør diskussionen føre til en konklusion om plantepro-
duktet skal betragtes som traditionelt på regionalt eller lokalt niveau eller 
betragtes som en etnisk fødevare eller som en ny fødevare hvor der kræ-
ves en risikovurdering ifølge reguleringen. 
For alle planteprodukter der defineres som nye på første trin tages be-
slutning på 2. trin om den generelle risikovurderings procedure. Den 
generelle risikovurderings procedure skal således definere omfanget og 
følgen af de videnskabelige data som skal være til rådighed for den fagli-
ge risikovurdering af produktet. 
For at gøre det lettere at introducere de såkaldte eksotiske frugter og 
grønt fra en region til en anden, anbefaler NNT at bruge konceptet history 
of use som en vigtig del af ansøgningen om markedsføring. I det omfang 
en ansøger kan fremvise data som støtter at et produkt har en history of 
safe use (historisk sikker anvendelse) kan godkendelse gives. 
For at støtte og lette tilgængeligheden af en høj kvalitet af “history of 
use” data til en ansøgning om markedsføring foreslår NNT udvikling af et 
verdensomspændende net af positive lister for planter som er kilde til 
fødevarer på enten globalt niveau, på forskelligt regionalt eller lokalt 
niveau eller kendt som etnisk fødevare forskellige steder. De individuelle 
lister skal reflektere anvendelsen af fødevareplanter i regionen, lokalt 
eller de etnobotaniske områder planterne stammer fra.  
Når alle lister er tilgængelige vil de give et samlet billed af verdens 
anvendte fødevareplanter. Forventningen hos NNT er at denne samlede 
datamængde fra disse lister vil gøre det lettere gensidigt at acceptere sik-
kerheden og fordelene af disse fødevareplanter på tværs af politiske, øko-
nomiske og kulturelle grænser. NNT anbefaler at alle listerne udvikles 
efter internationale anerkendte principper og bygger på internationale 
anerkendte kriterier for at blive gensidigt accepterede, f.eks. i WTO regi, 
og fremhæver at listerne baseres på information fra kilder som er trovær-
dige og passende og i høj kvalitet således, at det kan blive accepteret ved 
en kritisk videnskabelig vurdering.  
Rapporten giver anbefalinger indenfor fødevaresikkerheds området, 
hvor der stadig er begrænset videnskabelig viden. Alle koncepterne er 
relativt nye og principperne er endnu ikke fikseret af regulatoriske tradi-
tioner. Derfor anbefaler NNT stærkt at fortsætte den interaktive udveks-
ling af koncepter og ideer imellem aktører indenfor administration og 
videnskab i dette felt både horisontalt og vertikalt til at sikre, at de bedste 
regulerings og videnskabelige instrumenter vil blive anvendt. 
 Yhteenveto 
Maailmanlaajuisesti ihmisten päivittäinen energiasaanti kasveista tulee 95 
prosenttisesti noin 30 elintarvikekasvista. Euroopassa loput 5% päivittäi-
sestä kasviperäisestä energiasta saadaan noin 300 kasvilajista mm. yrteis-
tä. Sekä edellä mainitut merkitykselliset 30 että vähemmän merkitykselli-
set 300 kasvia voivat tarjota uusia elintarvikeaineksia kasvinosista, joita 
ei aiemmin ole käytetty elintarvikeketjussa. Merkittävin uusien elintarvi-
keainesten lähde on kuitenkin ne 7000 muuta kasvilajia, joita käytetään 
perinteisesti ihmisravintona muualla maailmassa. Tässä raportissa tarkas-
tellaan tilannetta, jossa Euroopan markkinoille tarjotaan elintarvikkeita 
näistä 7000 kasvista.  
Raportissa tarkastellaan sekä historiallista kokemusta elintarvikekas-
veista että kokemuksia ruokavalioomme tulleista aikaisemmista ja tuo-
reemmista uutuuksista kuten rapsi, lupiinin siemenet, kiwi hedelmä, pu-
nainen tarhapapu, karambola, nangai pähkinä, noni mehu ja kassava. 
Johtopäätöksenä todetaan, että joitakin uusia kasvipohjaisia elintarvikkei-
ta, esimerkiksi kassavaa,  tulisi tarkastella lähemmin silloin, kun niitä 
saatetaan markkinoille maissa tai alueilla, joissa puutuu perinteinen käyt-
tökokemus. 
Raportissa lähdetään Euroopan yhteisössä, Australiassa/Uudessa-
Seelannissa ja Kanadassa voimassa olevista uuselintarvikeasetuksista.  
Kaikissa kolmessa tapauksessa lainsäädäntö erottelee perinteiset kasvipe-
räiset elintarvikkeet uusista, sillä uusien on läpäistävä markkinointilupaa 
edeltävä turvallisuusarvio. Koska lainsäädäntö on uutta, EU:ssa vasta 
vuodesta 1997 alkaen, sekä säädöksen toimintamuodot että tieteelliset 
periaatteet ovat vielä kehittymässä. 
Tätä taustaa vasten raportissa on esitetty ehdotus kasvipohjaisten elin-
tarvikkeiden uutuuden tai perinteisyyden määritelmistä ja määritelmien 
perusteista. Raportissa on myös esitetty ehdotus tavasta, jolla sellaisten 
kasviperäisten elintarvikkeiden turvallisuus voitaisiin arvioida, joista ei 
löydy kirjattua kokemusta turvallisesta elintarvikekäytöstä. 
 
Pohjoismainen työryhmä suosittaa käyttöön: 
Kaksivaiheista toimintamallia, jossa ensivaiheessa todennetaan uutuus ja 
toisessa vaiheessa määritellään turvallisuusarviotarve ja varataan siihen 
resurssit. 
 
Hyödynnettäväksi maailmanlaajuista verkkoa maailmanlaajuisista, alu-
eellisista, paikallisista ja kansantieteellis-kasvitieellisistä luetteloista kos-
kien elintarvikekasveista. Tämä tieto auttaisi tehtäessä päätöksiä uu-
tuudesta ja toisaalta se olisi apuna turvallisuusarviossa. 
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Kaksivaiheisen toimintamallin ensimmäisessä vaiheessa riskinhallin-
nasta vastaavien tulisi muodostaa riski profiili (risk profile) yhteistyössä 
sidosryhmien, alan tiedemiesten ja kuluttajien edustajien kanssa. Työssä 
tulisi huomioida itse tuote, tieto arvioidusta käytöstä, aiempi käyttökoke-
mus (history of use), asiaan liittyvä arvomaailma kuten ihmisten terveys, 
taloudelliset ja muut mahdolliset vaikutukset, kuluttajien hyväksyttävissä 
olevat riskit ja hyödyt sekä sosiaalinen  riskien ja hyötyjen jakautuminen. 
Jäljempänä käsiteltävät kasviluettelot ovat oleellinen osa arvioitaessa 
aiempaa käyttökokemusta. Tässä käsittelyvaiheessa tulisi selvitetyksi 
onko kasviperäinen elintarvike perinteinen alueellisesti tai paikallisesti, 
onko se tietyllä alueella käytetty perinteinen etninen elintarvike vai onko 
se sellainen uusi kasviperäinen elintarvike, jolta edellytetään säädösten 
mukaista turvallisuuden arvioimista.  
Kaksivaiheisen mallin toisessa vaiheessa  riskinhallinnasta vastaavat 
päättävät yleisestä riskinarviossa omaksuttavasta asenteesta (risk as-
sessment  policy) kaikille ensi vaiheessa uusiksi määritellyille kasviperäi-
sille elintarvikkeilla. Riskinarviossa omaksuttava asenne määrittelee sen 
tieteellisen aineiston laajuuden ja aineiston esittämisjärjestyksen, joka 
tulee saattaa tieteellistä riskinarviota suorittavien saataville markkinoille 
saattamista edeltävän arvioinnin suorittamiseksi. 
Uutuuksien mahdollisimman sujuvan markkinoille saattamisen mah-
dollistamiseksi NNT suosittaa vierailta alueilta tulevien ns. eksoottisten 
hedelmien ja kasviksien lupahakemuksien perustaksi käsitettä ”aiempi 
käyttökokemus”. Tuote voidaan hyväksyä saatettavaksi markkinoille, 
mikäli hakemuksen tueksi jätetty aineisto vahvistaa tuotteen aiemman 
turvallisen käytön. 
Jotta hakemusten tueksi olisi käytettävissä mahdollisimman helposti 
korkealuokkaista ”aiempaa käyttökokemusta” tukevaa aineistoa suosittaa 
NNT kehitettäväksi maailmanlaajuista verkkoa elintarvikekasvien luette-
loista. Luetteloihin kerättäisiin hyväksyttävää aineistoa kasveista valmis-
tettujen elintarvikkeiden käytöstä maailmalaajuisesti, alueellisesti, paikal-
lisesti tai kansantieteellisiin ja kasvitieteellisiin tietoihin pohjautuen. Yk-
sittäisten luetteloiden tulisi kuvata kasviperäisen elintarvikkeen käyttöä 
sellaisilla alueilla tai paikoilla, joissa tuote on kehitetty elintarvikekäyt-
töön tai pohjaten kyseisten elintarvikekasvien kansantieteellisiin ja kasvi-
tieteellisiin taustoihin. Kun kaikki luettelot on luotu, antaisivat ne maail-
manlaajuisen näkemyksen kasviperäisten elintarvikkeiden käytöstä. NNT 
odottaa, että kaikista näistä luetteloista saatava tieto edesauttaisi yhteis-
ymmärrystä turvallisuudesta ja kasviperäisten elintarvikkeiden tai elintar-
vikeainesten eduista yli poliittisten, taloudellisten tai kulttuuristen rajojen. 
NNT suosittaa, että nämä luettelot laadittaisiin kansainvälisesti sovittujen 
periaatteiden mukaisesti ja ne pohjautuisivat kansainvälisesti hyväksyt-
tyihin periaatteisiin, jotta ne voitaisiin yhteisesti hyväksyä esimerkiksi 
WTO:ssa. NNT painottaa, että kaikkien luetteloiden tulisi perustua luotet-
tavaan ja  korkeatasoiseen tietoon ja hyväksyttäviin referenssiaineistoi-
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hin, jotta luettelot olisivat tieteellistä arviota tekevien asiantuntijoiden 
hyväksyttävissä. 
Raportti antaa suosituksensa sellaisella elintarviketurvallisuuden osa-
alueella, jossa toistaiseksi on vielä hyvin vähän tieteellistä kokemusta. 
Kaikki esitetyt konseptit ovat hyvin uusia, eikä periaatteita ole sovittu 
säädöksin. Siksi NNT suosittaa vakavasti jatkuvaa vuorovaikutteista kon-
septien esittämistä ja ajatusten vaihtoa riskinhallinnasta vastaavien ja 
tieteen edustajien välillä, jotta voitaisiin varmistaa parhaan mahdollisen 
lainsäädännöllisen ja tieteellisen työkalun valinta. 
 
 1. Introduction 
This report deals with a segment of the novel foods, namely novel plant 
foods and novel plant food ingredients (hereinafter just named: novel 
plant foods), with the main focus on novel foods derived from plants not 
known in the country or region. The report does not deal with foods de-
rived from genetically modified plants, but only foods derived from culti-
vated plants that may be developed through conventional breeding or 
plants from wild sources. 
The aim is to develop a guide to the safety assessment of whole foods 
derived from plants with no or limited documented history of safe con-
sumption in a country or region. For nearly all plant foods it is very diffi-
cult to obtain scientific data, which documents their history of safe con-
sumption even if they have been eaten for several hundreds of years. Ne-
vertheless according to the regulation of some countries there is a need to 
establish the safety of novel plant foods in order to accept their introduc-
tion in the market place.  
The scope of this report is therefore to discuss principles and concepts 
for a safety assessment of novel plant foods, with a main focus on new 
exotic fruits and vegetables with no history of safe consumption, with the 
final aim to propose a procedure for safety assessment based upon up-to-
date scientific knowledge. 
While there are well established ideas on how to address the safety as-
sessments of isolated and extracted plant products, like sugars, fats and 
other defined chemical entities, there are no common international ap-
proaches to assess the safety of complex foods such as fruits, vegetables 
and other plant parts derived from novel sources.  
During the last two decades a lot of attention has been paid to the 
safety assessment of genetically modified organisms (GMO) used as 
food. Several international reports have indicated that the safety assess-
ment strategy recommended for genetically modified foods to a large 
extent also could be used for other kinds of novel foods. Another conclu-
sion from many of these reports is that very little is known about the po-
tential long-term health effects of any traditional food (e.g. FAO/WHO 
2000). Nonetheless, most traditional foods are treated as being safe be-
cause no widespread occurrence of acute severe adverse effects is re-
ported after their consumption. Their safety have, however, rarely, if 
ever, been established. One example could be coffee. A large fraction of 
the population is able to identify at least some acute adverse effects but 
most people handle coffee as being safe to consume. Another conclusion 
from the experience with genetically modified plants is that such plants 
have been thoroughly assessed for their safety prior to marketing, which 
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is not the case for many other new whole foods. While it has been com-
monly accepted that for example food additives and pesticides should be 
thoroughly tested prior to being used or allowed in food production to 
secure that their level in the final food product would not constitute a 
health risk, foods from new plant lines or new exotic fruits and vegetables 
have not been evaluated to the same extent for potential adverse effects 
on health although there are several examples of risks connected to such 
foods (see chapter 4). 
Considering fruits and vegetables with no history of safe use there is a 
need for identifying potential safety issues. It is also important to identify 
the type of information which would be useful for a safety assessment of 
such foods, and which type of analysis or tests, if any, that might be re-
quired to obtain the information before marketing.  
Today countries such as Canada and Australia/New Zealand as well as 
the European Union (EU) have regulations for novel foods. The defini-
tion of what constitutes a novel food varies, but in common these regula-
tions requires a pre-market safety assessment of such foods. However, the 
scientific guidelines for performing risk assessments of novel foods are in 
general poorly harmonised and are still developing as more and more 
attention is paid to these foods and more experience about testing meth-
odology are obtained. Therefore, it would be very helpful to develop a 
common understanding of how such a safety assessment could be carried 
out based on present day knowledge. Our previous experience from tradi-
tional breeding of food plants, as well as experience with introduction of 
new foods from exotic plants, and more recently the pre-market approval 
of novel foods, will also feed into this process of developing guidance for 
safety assessment of novel food plants. 
Tightly connected to this issue is of course the definition of novel 
foods. The prerequisite for doing a safety assessment is the recognition of 
the food item as being novel within a regulatory framework. The defini-
tion of what constitutes a novel food is basically a management decision. 
This report will give some suggestions for an approach that might be 
useful for a management decision, which also illustrate the different roles 
of management and science in the process and underlines the need for 
keeping the two different sets of arguments apart. 
The overall aim of this report is thus to facilitate the introduction of 
novel plant foods into the market place through a clear definition of the 
roles of risk management and risk assessment in the process by explain-
ing what each part should do, and thereby bringing the harmonization 
process of safety assessments of exotic fruits and vegetables an important 
step further. 
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2. Regulations (EU and worldwide) 
The novel food regulations in the EU, Canada and Australia/New Zealand 
discussed below have been chosen as examples of regulations. UK is 
presented separately from EU due to its experience in safety assessments 
of a wide variety of novel foods prior to the introduction of the EU regu-
lation. It is not expected that prolonging the presentation of regulations 
with those of other countries will add to a great extent to the perspectives 
in the assessment and management of novel plant foods. 
2.1 The European Union 
The EU Novel Food Regulation was enacted January 1997 and came into 
force on 15 May 1997 with the principal objectives to protect the func-
tioning of the internal market within the Community, and to protect pub-
lic health. 
The first article of the EU-regulation: (EC) No 258/97 of the European 
Parliament and of the Council of 27 January 1997 defines novel food as 
foods and food ingredients which have not hitherto been used for human 
consumption to a significant degree within the Community and which fall 
under the following categories: 
 
a. foods and food ingredients containing or consisting of genetically 
modified organisms within the meaning of Directive 90/220/EEC; 
b. foods and food ingredients produced from, but not containing, 
genetically modified organisms; 
c. foods and food ingredients with a new or intentionally modified 
primary molecular structure; 
d. foods and food ingredients consisting of or isolated from 
microorganisms, fungi or algae;  
e. foods and food ingredients consisting of or isolated from plants and 
food ingredients isolated from animals, except for foods and food 
ingredients obtained by traditional propagating or breeding practices 
and having a history of safe food use;  
f. foods and food ingredients to which has been applied a production 
process not currently used, where that process gives rise to significant 
changes in the composition or structure of the foods or food 
ingredients which affect their nutritional value, metabolism or level 
of undesirable substances. 
 
The original European Novel Food legislation focused mainly on geneti-
cally modified organisms (a and b above) but this part has now been de-
tached from the Novel Food Regulation and included in the new EC regu-
lation, No. 1829/2003, on genetically modified food and feed. The re-
maining part of the Novel Food Regulation (No. 258/97) will soon be 
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revised. This report addresses only the plant part of category (e) of the 
remaining Novel Food Regulation. 
The European Novel Food Regulation establishes a system for pre-
market approval of novel foods, which thus have to be subjected to a 
safety assessment before they are placed on the market in the Commu-
nity. The legislation aims at providing the public with an assurance of the 
safety of novel foods. Before the Novel Food Regulation was put in pla-
ce, such products did not have to go through a pre-marketing approval 
before being introduced on the market. Now applicants interested in plac-
ing a novel food on the European market have to submit an application to 
the competent authority of the member state where the product is first to 
be placed on the market, and send a copy of the request to the Commis-
sion. That competent authority is then responsible for performing a pri-
mary safety assessment. 
When the Novel Food Regulation with its many different types of 
novel foods was in place, the scientific community was given the difficult 
task of addressing how the required safety assessment of these products 
should be performed. This question was addressed in a Commission Rec-
ommendation of July 1997 (97/618/EC) concerning the scientific aspects 
and the presentation of information necessary to support applications for 
the placing on the market of novel foods and novel food ingredients and 
the preparation of initial assessment reports under regulation EC No 
258/97 of the European Parliament and of the Council (European Com-
mission, 1997). It seems clear that these guidelines have been developed 
with special emphasis on novel foods produced by GMO or novel proc-
esses (categories a, b, and f above) and less so with regard to novel foods 
resulting from traditional breeding or import of products from countries 
outside the EU.  
2.1.1 United Kingdom  
The national initiative about assessment of novel food in the United 
Kingdom is now subordinate to the regulations of the European Union 
but was initiated long before the introduction of European regulations in 
the novel food area in 1997. 
In October 1988, the ministers of the Ministry of Health and the Min-
istry of Agriculture, Fisheries and Foods (MAFF) announced that the 
Advisory Committee on Irradiated and Novel Foods would be reconsti-
tuted as the Advisory Committee on Novel Foods and Processes 
(ACNFP) to reflect more accurately the rapidly developing area of food 
biotechnology. The Committee was established as an independent body 
of experts whose remit has been only slightly changed over the period 
1988 to 2003 and which today is “to advise the central authorities respon-
sible, in England, Scotland, Wales and Northern Ireland, respectively, on 
any matters relating to novel foods and novel food processes, including 
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food irradiation, having regard where appropriate to the views of relevant 
expert bodies” (ACNFP, 2004). 
The experience of ACNFP in making risk assessments of various ty-
pes of novel foods such as quorn, lupins, quinoa and passion fruit seed oil 
can give valuable contributions to the discussion in this report. Examples 
of novel food risk assessments undertaken by the ACNFP can be found in 
their annual reports (ACNFP 1989-2004). 
2.2 Canada 
In Canada, novel foods must undergo a pre-market safety assessment.  
The regulation is part of the Food and Drug Regulations and was promul-
gated in November 1999.  A guideline for safety assessment of novel 
foods was produced in 1994, i.e. prior to the regulations coming into for-
ce. This guideline is in the process of being revised and updated to reflect 
both the more recent regulations, international agreement reached on the 
conduct of food safety assessment of foods derived from recombinant-
DNA plants and microorganisms through Codex Alimentarius and ad-
vancements in knowledge and experience in the safety assessment of 
novel foods derived from plants and microorganisms.  A draft that was 
issued for consultation may be consulted on the Health Canada website at 
www.novelfoods.gc.ca.  The definition of novel food given in the 1994 
guideline is superseded by that found in the regulation. 
 
The Canadian Food and Drug Regulations (Health Canada 1999) states 
that “novel food means 
 
a. a substance, including a microorganism, that does not have a history 
of safe use as a food;  
b. a food that has been manufactured, prepared, preserved or packaged 
by a process that has not been previously applied to that food, and 
causes the food to undergo a major change; and 
c. a food that is derived from a plant, animal or microorganism that has 
been genetically modified such that 
 
• the plant, animal or microorganism exhibits characteristics that 
were not previously observed in that plant, animal or 
microorganism,  
• the plant, animal or microorganism no longer exhibits 
characteristics that were previously observed in that plant, animal 
or microorganism, or  
• one or more characteristics of the plant, animal or microorganism 
no longer fall within the anticipated range for that plant, animal 
or microorganism.”  
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Also, "genetically modify" means, ”to change the heritable traits of a 
plant, animal or microorganism by means of intentional manipulation”. 
Therefore, traditional breeding, for example, could result in a novel food 
if it produced a plant modified as described in part (c) above. 
The Canadian regulations require a pre-market notification of novel 
foods to Health Canada, the federal health department. The determination 
that something is novel is the first step and considered distinct from the 
safety assessment, which is second.  The notification must contain a de-
scription of the novel food together with information respecting its devel-
opment, details of the major change, if any, details of the method by 
which it is manufactured, prepared, preserved, packaged and stored, in-
formation respecting its intended use and directions for its preparation, 
information respecting its history of use as a food in a country other than 
Canada, if applicable, information relied on to establish that the novel 
food is safe for consumption and information respecting the estimated 
levels of consumption by consumers of the novel food. The pre-market 
notification application should also include the text of all labels to be 
used in connection with marketing of the novel food. Based on the pre-
market notification, the Director within 45 days after receiving the notifi-
cation decides whether the information is sufficient to establish that the 
food is safe for consumption or if additional information of a scientific 
nature is necessary in order to assess the safety of the novel food. The 
Director has to assess the product within 90 days after receiving the addi-
tional information requested, and, if the novel food is established as safe 
for consumption, notify the manufacturer or importer in writing that the 
information is sufficient. 
The Guidelines for the safety assessment of novel foods that were 
published in Canada in 1994 (Health Canada 1994) were developed 
largely to address the safety of GMO and novel processing technology. 
The revised guidelines will be much more comprehensive and provide 
guidance on the data that may be needed to support the safety of all types 
of novel foods derived from plants and microorganisms. 
These guidelines take into consideration that a food, such as an exotic 
fruit or vegetable, that has not previously been sold to any significant 
extent in Canada may have a history of safe use elsewhere.  It may suffice 
to demonstrate this history. The revised guidelines include a definition of 
history of safe use.  This is as follows: 
“A substance may be considered to have a history of safe use as a food 
if it has been an ongoing part of the diet for a number of generations in a 
large, genetically diverse human population where it has been used in 
ways and at levels that are similar to those expected or intended in Can-
ada”. The fact that a product has had a history of use according to the 
above definition in a jurisdiction with a similar food safety system would 
increase the level of confidence in the evidence presented. The following 
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information would be needed to support a claim that a product has a his-
tory of safe use:  
 
• Historical evidence indicating ongoing, frequent consumption by a 
cross-section of the population where it has been used over several 
generations (i.e. 100 years). This evidence may be derived from 
various sources including, but not limited to, scientific publications 
and patents, non-scientific publications and books, cookbooks, books 
on the history of food culture, and/or affidavits from two or more 
independent, reputable authorities that include well-documented 
accounts of the way the food is used and how they know it has the 
history it does. Limited usage or short-term exposure would not be 
adequate to demonstrate a history of safe use.  
• A declaration of any possible adverse effects linked to the food 
documented in its country of origin and/or a country where there is a 
high degree of consumption.  
• A description of the standard methods of commercial and/or domestic 
processing and preparation for consumption.  
• A description of how the food is cultivated or (if from wild sources) 
harvested.  
• Amounts of the food that people are likely to consume in Canada, 
including typical serving sizes and expected frequency of 
consumption, at both average and extreme high consumption levels.  
• Analysis of the composition of the food based on randomly selected, 
statistically valid samples. This analysis should include proximate 
data as well as amino acid profile, fatty acid profile, mineral and trace 
mineral composition and vitamin composition, as well as any 
nutrients, antinutrients and bioactive phytochemicals known to be of 
particular interest in the product. The analysis should pay special 
attention to the presence of compounds in the food, which may have 
implications for the health of any groups of the Canadian population 
(e.g. possible toxicants or allergens or unusually high levels of 
nutrients in the food source or final food product).  
• Metabolism and/or gastrointestinal effects in humans. 
 
The submission should include reliable, high quality information and 
reference sources. Anecdotal evidence will be given less weight than 
scientifically derived data. Information on the history of human exposure 
will be particularly important where there are traditional handling or coo-
king requirements for a food that is novel. This information will need to 
be made available to consumers in a consistent manner. A current exam-
ple of this is the advice regarding the necessity for a minimum period of 
vigorous boiling when cooking various dried beans. 
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2.3 Australia/New Zealand  
In Australia and New Zealand novel foods are regulated by Standard 
1.5.1 – Novel Foods of the Australia New Zealand Food Standards Code.  
The Standard was introduced in December 1999 and the prohibition of 
the sale of novel food, unless listed in a table in that Standard and in 
compliance with any conditions of use specified in that table, came into 
force from June 2001.  The purpose of the Standard is to ensure that non-
traditional foods, which have features or characteristics that raise safety 
concerns, will undergo a risk-based safety assessment before they are 
offered for retail sale for direct consumption in Australia and/or New 
Zealand.  Novel foods are a subset of non-traditional food.   
 
Standard 1.5.1 introduced December 1999 defines non-traditional food 
and novel food as follows:  
 
• non-traditional food means a food which does not have a history of 
significant human consumption by the broad community in Australia 
or New Zealand. 
 
• novel food means a non-traditional food for which there is 
insufficient knowledge in the broad community to enable safe use in 
the form or context in which it is presented, taking into account – 
 
a) the composition or structure of the product; or 
b) levels of undesirable substances in the product; or 
c) known potential for adverse effects in humans; or 
d) traditional preparation and cooking methods; or 
e) patterns and levels of consumption of the product. 
 
It is not specifically stated in the Standard whether or not it applies retro-
spectively.  However, it is unlikely, though not impossible, that a product 
on the market in Australia and/or New Zealand prior to the introduction 
of the Standard would be considered to be ‘non-traditional’. 
Food Standards Australia New Zealand has developed two documents 
(FSANZ 2004a, 2004b) to assist in interpreting the Standard as follows: 
 
• ‘Format for applying to amend the Code – Novel Foods’ which 
contains a template which can be used when making an application 
for permission to use a novel food (Attachment 2); and 
• ‘Guidelines to assist in applying to amend the Australia New Zealand 
Food Standards Code – Novel Foods’ which provides details of the 
operation of the standard, descriptions of the likely categories of 
novel foods, a decision tree for determining the novelty of a food, 
data requirements for the assessment of novel foods and a record of 
views formed in response to inquiries with respect to novelty. 
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The guidelines document was completely reviewed and updated in early 
2004. A table presenting a record of views formed in response to inquir-
ies with respect to novelty was included.  The table presents the outcome 
view with respect to whether a particular food is: a) traditional or non-
traditional; and b) novel or not novel, with respect to the definitions in 
Standard 1.5.1. Advice as to the potential novelty of the food is provided 
by the internal Novel Foods Reference Group.  A final determination as 
to the novelty of a food is made in conjunction with relevant enforcement 
agencies. 
For non-traditional foods, two steps may be necessary to meet the re-
quirement of this Standard: an initial step to assess the novelty of the 
food, including identification of potential hazards connected to the food, 
and a second step to assess the safety of the novel food.  
The guidelines document also lists some potential categories of novel 
foods, of which the single ingredient foods/whole foods category includes 
the subject of this report: foods that have not traditionally formed part of 
the diet in the broad community in Australia and New Zealand, such as 
foods from other parts of the world, traditional indigenous foods con-
sumed by specific groups in the community, or new foods produced from 
traditional breeding techniques. The guidelines document states that 
“while there are many new foods on the market, it is likely that only those 
where there is some evidence of potential adverse effects would be con-
sidered novel”.  
A safety assessment will be undertaken of those non-traditional foods 
for which, in the words of the Standard, there is “insufficient knowledge 
in the broad community to enable safe use in the form or context in which 
[they are] presented”. An assessment of the level of knowledge about the 
safe use of a non-traditional food in the broad community of Australia 
and New Zealand is made in determining novelty.  
2.4 Conclusions on regulations 
The Novel Food legislation within the European Community and Austra-
lia/New Zealand include traditional foods with no documented history of 
food use in the definition of novel foods (the specific term in Austra-
lia/New Zealand is “non-traditional food”). Although there exist some 
common understanding in defining novel food, there is still room for 
interpretation and therefore a need to give a more precise definition in 
order to diminish this grey area. 
In Canada and Australia/New Zealand the applications are handled by 
central authorities, whereas novel food applications within the EU are 
handled by the competent authority of the member state where the novel 
food is planned to be introduced on the market and the European Com-
mission. The safety assessment of whole foods is far from routine and no 
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harmonised international guidelines exist on how such assessments 
should be performed. However, some experiences have been gained in 
individual countries and in EU, which now can guide the process for-
ward. 
 3. Historical experience 
3.1 Food plants and food plant toxins 
Nowadays the general advice on good eating habits from a nutritional 
view point is to eat a variety of fruits and vegetables each day to ensure 
the intake of the necessary amount of nutritionally important proteins, 
amino acids, fats and fatty acids, complex carbohydrates, fibers, vitamins 
and minerals together as well as a variety of plant metabolites such as 
plant phenols, isothiocyanates, indoles and carotinoids with and without 
nutritional relevance. It is now recognized that an upper safe level exists 
for most of these plant constituents, and that many food plants as part of 
their self-protection against plant diseases due to microbes and pests form 
toxic plant constituents without any nutritional benefit, but maybe a 
health benefit to humans. Intake of plant foods like cassava (Manihot 
esculenta Crantz) and grasspea (Lathyrus sativus L.) may give rise to 
acute and chronic intoxications in human. In spite of that, the starch-filled 
roots of cassava have a major role in today’s food supply in many tropical 
regions. The roots contain cyanogenic glycosides, and raw or inade-
quately processed roots may cause acute symptoms or chronic neurologi-
cal disorders (see 4.8 for further details). Excessive consumption of the 
seeds of the legume grasspea causes lathyrism, a neurodegenerative and 
irreversible spastic paraparesis (Spencer et al. 1986, Getahun et al. 2003). 
The toxic substance is the neuroexcitatory amino acid β-N-oxalyl-α,β-
diaminopropionic acid (ODAP), but the direct effect of ODAP is still not 
figured out (Rao 2001). Since grasspea is highly drought- and flood-
resistant, the seeds may still constitute a major part of the diet during 
famine crisis. Outbreaks of lathyrism epidemics have occurred within the 
last ten years in Afghanistan, Nepal and Ethiopia. Recently there has been 
a renewed interest in cultivating grasspea in Italy and Poland (Getahun et 
al. 2005), and the first variety of grasspea (Ceora) with low level of 
ODAP is just released in Australia (Siddique and Hanbury 2005).  
As the above-mentioned examples show, plant foods may nowadays 
give rise to safety concerns even in populations accustomed to their use.  
The examples also illustrate that proper use of plant foods both from a 
nutritional and safety point of view is the basic prerequisite for a stable 
and solid development and maintenance of the variety of human cultures 
and societies all over the world.  
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3.2 The Age of Exploration 
Since prehistoric times and over history new food items and new methods 
to prepare foods have gradually spread and enriched the European food 
supply. These introductions have generally been slowly implemented. 
Already our ancestors, the hunter-gatherers were forced to broaden their 
food resource base to encompass a wide array of food that was previously 
ignored in an attempt to overcome food shortages. Data supporting this 
“broad-spectrum revolution” hypothesis has mainly been of faunal origin 
such as type of bones found but recent data from caves in the Levant 
confirms that the 25.000 years old plant material recovered were both 
broad in origin (142 taxa) and with a high amount of small-grained gras-
ses compared to cereals (wild wheat and barley) (Weiss et al. 2004). In 
the following 15.000 years, the cereals gradually replaced these small-
grained grasses. The proper shift from hunting and gathering to agricul-
ture took place some 10.000 years ago in the Oriental region and broad-
ened to the Europe, central Asia and India through the next millennia. 
Although the reasons for this “Neolithic revolution” are still not fully 
understood, the resulting domesticated plants are major food component 
in Europe such as wheat (developed to Triticum aestivum), barley (Hor-
deum vulgare) and pea (Pisum sativum) (Zohary and Hopf 2000).   
In historic times the single remarkable and epoch-making event, 
which produced a mass introduction of novel foods in Europe, was the 
exploration of the “new” world. A large part of the plant foods considered 
nowadays as an integrated part of the European diet was first introduced 
in Europe some 400-500 years ago, following this “Age of Exploration”. 
The food plants introduced during this period include potato (Solanum 
tuberosum), tomato (Lycopersicon esculentum), maize (Zea mays), 
groundnut (Arachis hypogaea) and pepper fruit (Capsicum annuum), 
which now are important staple foods and feeds. In the same period also 
cacao, vanilla, and allspice and a series of other spices, now highly ap-
preciated as culinary delicacies, came along. 
When the “Age of Exploration” began, the Solanaceae family was re-
puted in Europe for its toxic and medicinal members. It is therefore un-
derstandable that there was some resistance to accept food from this plant 
family such as potato, tomato and pepper fruits in Europe. These plants 
domesticated in central and south America in prehistoric times, were 
widely consumed in the Americas before Columbus. Today they are cul-
tivated throughout the world and are some of the world's most important 
vegetables/tubers. They were all introduced in Europe shortly after 1500 
AD but only pepper fruit was readily accepted as a food – as a substitute 
for pepper (Piper nigrum). Tomato can illustrate the slow acceptance of 
Solanum-like fruits in Europe. It was first in the late 18th century that 
tomatoes were being grown and eaten in abundance in Italy and Spain. 
By 1800, when tomatoes had become the most common fruit in Spain, 
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they were starting to be eaten in France, while in Northern Europe they 
were still regarded with suspicion.  
3.3 Before the EU regulation 
More recently, but before the EU regulation on novel food came into 
place in 1997, a number of exotic food plants has been introduced on the 
European food market. These exotic foods have presumably been placed 
on the market based on the assumption that their safety could be assured 
by their use as food in other parts of the world. Well-known examples are 
aubergine (Solanum melongena), squash (Cucurbita pepo), kiwi fruit 
(Actinidia delisiosa, A. chinensis), star fruit (Averrhoa carambola), cape 
gooseberry (Physalis peruviana) and durian fruit (Durio zibethinus). 
The occurrence of toxic glycoalkaloids in different Solanaceae plants 
such as potatoes (S. tuberosum) has been investigated (Andersson 1999). 
In a 1984 review of the literature, 12 separate reports of potato glycoalka-
loid poisoning, involving more than 2000 cases with about 30 deaths, 
have been presented. Moreover, the review argues that most of the mild 
and even the more serious “solanine” poisonings go unrecorded and are 
diagnosed as “gastroenteritis” (Morris and Lee, 1984). The content of 
total glycoalkaloids varies considerably between the different potato va-
rieties. Based upon a risk assessment of the content of total glycoalka-
loids in potatoes, the Nordic Group on Food Toxicology and Risk As-
sessment suggested back in 1990 a Maximum Tolerable Level of total 
glycoalkaloids in potatoes on 200 mg/kg unpeeled potatoes with sugges-
tion to reduce the level to 100 mg/kg for new varieties (Slanina 1990). 
This limit is more or less adopted in development and marketing of new 
potato varieties, as well as in potato sale. 
The potato case illustrates the kind of acute human health problems 
the unconsidered introduction of novel plant foods may lead to. Another 
example is the potential of the kiwi fruit to provoke human allergenicity 
(see chapter 4). No studies have been found investigating the influence of 
the novel plant foods on human long-term health effects such as cancer 
and cardiovascular disease in Europe. 
3.4 After the EU regulation 
Traditionally, foods have been considered safe because there has been no 
reported evidence of adverse effects over time, and/or because adequate 
knowledge has been acquired in the community with respect to food 
processing or preparation to address any identified hazard. The introduc-
tion of the Novel Food legislation in Europe, with its definition of novel 
foods has created a need for the establishment of the safety of exotic 
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fruits and vegetables novel in Europe. Since the 15 May 1997 these prod-
ucts have to be assessed for their safety, which have to be found accept-
able, before the products are placed on the market. It has been suggested 
that a number of plant foods introduced in Europe over time and now 
being an integrated part of the European diet would never have been ac-
cepted and thereby reached the European market, if they should have 
passed a pre-market approval like the one now being required according 
to the EU Novel Food regulation (EC No. 258/97). The main difficulties 
experienced so far in relation to novel plant foods in EU since 1997 relate 
to defining the borders of the area of regulation (“What is novel?”) and to 
the lack of regulatory and scientific consensus on the type of safety data 
needed to perform the safety assessment and complete the premarket 
approval for foods deemed to be novel. This report addresses these ques-
tions. 
3.5 Conclusions on historical experience 
Both in prehistoric and historic times a number of novel plant foods have 
been accepted as part of the European food supply on the assumption that 
their safe intake is assured by their previous use in other parts of the 
world. Acute intoxications due to intakes of potatoes with high concentra-
tions of glycoalkaloids are well known in Europe. No long-term adverse 
health effects due to plant foods have been reported, but at the same time 
no European epidemiological studies have investigated this issue in a 
systematic manner.  
 4. Examples – past and present. 
The following examples on introduction of plant foods, taken from the 
past as well as from recent years, have been compiled to illustrate various 
toxicological and regulatory aspects relevant to consider when new exotic 
fruit and vegetables are to be introduced on the market. The case studies 
illustrate problems or aspects in relation to, e.g. allergy, occurrence of 
natural toxins and history of safe use. 
For each case the presentation is subdivided into a background sec-
tion, a section on health and safety issues and a section regarding the 
assessment of latter issues. The cases can be subdivided in those “novel” 
plant foods, which already were introduced at the European food market 
some years ago like rapeseed, kiwi fruit, red kidney bean and carambole, 
those plant foods which were introduced only recently like lupin seed, 
nangai and noni juice, and those which could give rise to health and safe-
ty considerations in Europe if they were to be introduced like cassava. 
4.1 Rapeseed  
Background:  
Domestication of Oilseed Rape is believed to have occurred in the early 
Middle Ages in Europe. At that time rapeseed oil was used primarily as 
oil for lamps and later as lubricants for steam engines. After the Second 
World War the interest in rapeseed breeding was intensified and directed 
to improve agronomic characters and oil quality. Animal studies have 
indicated as early as 1949 that consumption of large amounts of rapeseed 
oil with high levels of erucic acid could be detrimental (Boulter 1983). 
Therefore concerns about the nutritional safety of rapeseed oil and the 
potential impact on human health forced plant breeders to search varieties 
with low level of erucic acid in rapeseed oil. The first low erucic acid 
varieties in Brassica napus and in B. rapa were released in 1968 and 
1971, respectively. 
Rapeseed is also valuable for its meal, which is today used as a high 
protein feed supplement for livestock and poultry. Before the late 1970’s 
rapeseed meal (by-product after oilseed processing) could only be used in 
smaller amounts as feed due to the presence of glucosinolates, which 
gave low palatability and goitrogenic effects. These adverse effects led to 
development of varieties of rapeseed combining low levels of both glu-
cosinolates and erucic acid (double low varieties). The plant breeding 
toward lower level of erucic acid in the oilseed rape oil continues and 
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canola varieties have replaced all other varieties (FSANZ 2003) (canola 
refer to B. napus or B. rapa lines containing less than 2% of the total fatty 
acids as erucic acid).  
Health and safety issues: 
From rat studies erucic acid is reported to be responsible for development 
of myocardial lipidosis and for heart lesions but a number of reasons has 
suggested that the rat model is not an appropriate model to determine 
whether erucic acid may pose a risk for human health, e.g. the fatty acid 
metabolisms in the rat is dissimilar to that of adult pig and primates, mak-
ing rats highly susceptible to myocardial lipidosis and to necrosis and 
fibrosis in the hearts. Suckling pigs, however, are also developing myo-
cardial lipidosis and scar formation, suggesting that the immature myo-
cardium and/or liver may be less able to oxidise erucic acid. Therefore it 
seems reasonable to expect that (young) humans would also be suscepti-
ble to myocardial lipidosis and scar formation in the heart following ex-
posure to high level of erucic acid (FSANZ 2003). Directive 76/621 of 
the European Community sets the maximum level of erucic acid in oils 
and fats intended for human consumption to 5% of the total level of fatty 
acids. Today most of the oils from commercial oilseed rape have lower 
than 1% erucic acid of the total fatty acids (FSANZ 2003).  
Canola or double low oilseed rape oil (high oleic acid content) is not 
considered a novel food in EU, as it is unprocessed oil that were extracted 
from a conventionally bred rape variety and used in food production be-
fore 1997. However, the oil falls outside the Codex specification for un-
processed rapeseed oil with respect to the content of oleic and linolenic 
acids. It has a similar fatty acid profile, though, to processed rapeseed 
oils. 
4.2 Lupin seed  
Background: 
The plant part used for human consumption is the dried seeds of either 
the White lupin (Lupinus albus L.), or of the Narrow leaved lupin also 
known as Blue lupin (Lupinus angustifolius L.), both annual upright 
plants belonging to the Fabaceae family. White lupins are grown in the 
Mediterranean area, North Africa and Australia. Narrow leaved lupin 
with low alkaloid content has been extensively cultivated in Australia 
from the 1980s and accepted for human consumption there. Both lupins 
contain a mixture of various quinolizidine alkaloids. For White and Nar-
row leaved lupin, cultivars with high and low alkaloid content exist.  
Seeds of L. albus with high alkaloid content were used in the Mediter-
ranean area as a snack food before 1997. The plant is included in the 
NETTOX-list as a food plant in Europe. The bitter seeds need soaking 
 Risk Assessment and Risk Management of novel Foods 39 
followed by cooking until bitterness disappears before they can be safely 
consumed. In 1998 France accepted the use of up to 10% of lupin flour 
made from a variety of white lupin with low alkaloid content as a food 
ingredient provided that the alkaloid content did not exceed 200 mg/kg. 
For low-alkaloid-containing L. angustifolius varieties the UK introduced 
maximum levels of the total alkaloid content (200 mg/kg) and the content 
of a group of mycotoxins named phomopsins (5 μg/kg). 
The development of cultivars with low alkaloid content has widened 
the possible use of lupins since the seeds can be used without further 
preparation. Flour from the seeds can be used in bread, pastry, biscuits 
and pasta. Lupin seeds can also be used to produce food ingredients such 
as protein isolates and lupin ’milk’ (similar to soya ’milk’) and can be 
used instead of soy beans as a food ingredient or in the production of a 
number of Asian fermented foods. Whole seeds can be used in soups and 
stew, sprouted for use in salads, and roasted as a snack food (ACNFP 
1996).  
Health and safety issues: 
Symptoms of intoxication after ingestion of lupin seeds with high alka-
loid contents arise 1-14 hours after the consumption and include dry 
mouth, muscular weakness, disturbed balance, sweating, palpitation, 
blurred vision, mydriasis (i.e. dilated pupils), urine retention, gastric and 
intestinal troubles and abundant ventricular extrasystoles. Three cases of 
lethality have been described in young children. Based on these human 
data, the deadly dose of alkaloids for a child was assumed to be 11-25 
mg/kg b.w. The dose that causes acute effects in adults has been esti-
mated to 25-46 mg/kg b.w. (Schmidlin-Meszaros 1973). The acute oral 
LD50 of an alkaloid mixture from L. angustifolius was 2279 mg/kg body 
weight in rats dosed shortly after feeding and 2401 mg/kg body weight in 
fasted rats (Petterson et al. 1987). In a 90-day study in rats fed seeds from 
L. angustifolius, the no observed adverse effect level (NOAEL) was 28 
mg/kg body weight for male rats and 34 mg/kg body weight for female 
rats (Robbins et al. 1996). Cows that during pregnancy grazed on wild 
American lupin species containing the quinolizidine alkaloid anagyrine 
delivered calves with congenital defects described as ‘crooked calves 
disease’ (Panter and Keeler 1993). This very active quinolizidine alkaloid 
is, however, not present in seeds of L. albus and L. angustifolius (Wink 
et al. 1995). Dwarfism in calves and incomplete development of the 
distal limbs in lambs has been attributed to cows or ewes grazing on an-
other lupin species Lupinus cosentinii (Allen 1998). 
Safety assessment: 
Lupin seeds derived from Lupinus albus and L. angustifolius are not con-
sidered novel foods within the EU legislation because of a history of con-
sumption before 1997. Therefore, neither seeds nor lupine flours from 
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low-alkaloid containing cultivars need an EU evaluation with regard to 
safety when used as food. However, in the United Kingdom the Advisory 
Committee on Novel Foods and Processes (ACNFP) evaluated the food 
safety of seeds from L. angustifolius based on two 90-day toxicological 
studies in rats, a multigeneration study in rats fed seeds from L. albus, 
data on the metabolic fate of lupin alkaloids and their pharmacological 
activity (ACNFP 1996). ACNFP concluded that the seeds of these species 
were safe to use provided that the total alkaloid level was less than 200 
mg/kg seeds or derived lupin products and that the level of phomopsins 
was below 5 µg/kg. The Committee concluded that although lupin flour 
appeared to be capable of inducing allergic reactions in susceptible indi-
viduals, the proportion of the total population likely to show such reac-
tions would be less than that reacting to existing food allergens such as 
soy proteins. The Committee also noted that cross-reactivity between 
lupins and soybean allergens (or other pulses) may exist. It was recom-
mended that relevant health professionals and support groups should be 
informed of the introduction of lupin-based foods into the UK market 
(ACNFP 1996). No information to the consumers seems to have been 
required. Data on the difference in sensitivity between man and rat to the 
acute effects of quinolizidine alkaloids from L. albus and L. angustifolius 
as well as data showing that quinolizidine alkaloids from some lupin spe-
cies may effect development in ruminants seem not to have been taken 
into consideration in the ACNFP safety evaluation.  
Lupins, which were introduced on the Franch market in 1998, have 
caused seven of the 107 cases of severe anaphylaxis due to food con-
sumption according to a report by French allergists (Morisset 2003). In 
comparison, well-known allergens like various tree nuts resulted in 16 
cases, peanut in 14 cases, shellfish in 9 cases, and the latex-fruit group 
(avocado, kiwi, fig, banana) in 9 cases (Morisset et al. 2003). Recently in 
UK, a case of anaphylaxis in a woman was attributed to lupin flour used 
on onion rings in a restaurant meal (Radcliffe 2005). In Norway a person 
reacted with allergic symptoms after eating bread that contained lupin 
flour that was not included on the ingredient list. In both cases the pa-
tients were peanut-allergic. None of the papers dealing with lupin allergy 
specifies whether the allergic reactions are caused by L. albus or L. an-
gustifolius. 
Lupin flour was not included in the list of potentially allergic ingredi-
ents that should be specifically labelled by food manufacturers according 
to the directive on food labelling that came into force in Europe in No-
vember 2004 (Radcliffe 2005). Radcliffe (2005) suggests that since peo-
ple with peanut allergy (around 1% of the population in UK) seem to be 
at a particular risk they should be advised to avoid all products containing 
lupin until they can be specifically tested.  
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4.3 Kiwi fruit 
Background:  
The kiwi fruit (Actinidia deliciosa (A.Chev.) CF Liang et AR Ferguson) 
belonging to the family Actinidiaceae, is a plant native to China. Seeds 
were taken to New Zealand in 1904, and almost all kiwi cultivars outside 
China are descendants from this collection including the “Hayward” cul-
tivar (the traditional green flesh type of kiwifruits) (Ferguson 1999). Most 
of the recently commercialised hairless ‘kiwifruits’ with soft skin and 
yellow flesh, e.g. Hort16A, is actually from the species A. chinensis (yel-
low flesh type) (commercialised as Zespo Gold Kiwi) (Ferguson 1999).  
Health and safety issues: 
Acute allergic reactions to kiwi fruit were first described in 1981. Since 
then numerous reports have appeared describing allergenicity of kiwi. 
Kiwifruits has now become one of the major elicitors of plant food al-
lergy. The symptoms of most patients with kiwifruit allergy are confined 
to the oral allergy syndrome. Some individuals show more severe reac-
tions including angioedema, pharyngeal swelling, dyspnoea, urticaria, 
vomiting, and even cardiovascular collapse (Lucas et al. 2003).  
Kiwifruit is involved in the pollen-fruit syndrome (birch and grass 
pollen cross reactivity) and the latex fruit syndrome. Half of the patients 
with latex allergy show an allergy towards avocado, banana, chestnut, 
kiwifruits and other fruits (Lucas et al. 2003).  
Recently it is reported that the allergen composition of extract from 
the A. deliciosa ‘Hayward’ type of kiwifruit differ from extract of the A. 
chinensis ‘Hort16A’ type. Both cultivars express phytocystatin and a 
thaumatin-like protein as allergens. Two allergens with homologies to 
chitinases were only found in the ‘Hort16A’ type of kiwifruit, whereas 
actinidin was detected exclusively in the green kiwifruit (Bublin et al. 
2004).  
“Baby kiwi” or “berry kiwis” are developed from Actinidia arguta and 
can be grown in colder climates, even in Denmark. We know that the 
level of actinidin in A. arguta generally is higher than in A. deliciosa, 
therefore it is expected that most “berry kiwis” will have a higher poten-
tial for eliciting allergenic reactions.    
Safety assessment: 
The term “kiwi fruit” covers fruits collected and marketed from several 
species (at least 4), without considering the potential differences between 
these species in relation to health and safety issues (allergy). It is in fact 
possible in the breeding programme to incorporate such elements.  
Another question is what are the limits for the name kiwi. The kiwi 
name already covers fruits from at least 4 Actinidium species and in addi-
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tion rootstocks for the scion are often from other species, e.g. A. po-
lygama, influencing the fruit characterization.  
4.4 Red kidney bean  
Background: 
Kidney beans are kidney shaped mature dried seeds of the common bean 
or garden bean (Phaseolus vulgaris L.), a member of the Fabaceae fam-
ily. Two major gene pools of Phaseolus vulgaris have been identified and 
the kidney bean is a representative of the Andean gene pool (Southern 
Peru, Chile, Bolivia and Argentina) and has been cultivated for at least 
7000 years (McClean et al. 2004). The common bean was introduced into 
Europe through the Columbian exchange and the first detailed description 
of common bean in Europe was published in 1543 in the Herbal of Fuchs 
(Gepts 2002).   
Health and safety issues: 
The common bean (Phaseolus vulgaris) contains a family of plant de-
fence proteins that includes phytohemagglutinin (PHA). PHA is a lectin 
that binds to the glycans of the intestinal mucosa of mammals and acts as 
a mitogen. In red kidney beans the level of PHA is particular high com-
pared to most other types of beans, and it is necessary to inactivate the 
PHA in red kidney beans before human consuming.  
Safety assessment: 
All persons, regardless of age or gender, appear to be equally susceptible 
to toxic lectins; the severity being related to the type of lectin and the 
dose ingested. Lectin intoxications are usually caused by the ingestion of 
raw or soaked kidney beans that have not been boiled enough. These 
beans may have been consumed as such or in salads or casseroles. As few 
as a couple of raw red kidney beans may be able to cause intoxication. 
Onset of symptoms occurs from between 1 to 3 hours after consumption, 
and is usually characterised by an extreme nausea followed by vomiting. 
Diarrhoea develops somewhat later (from one to a few hours), and some 
persons report abdominal pain. Hospitalisation is sometimes needed, but 
recovery is usually rapid (3 - 4 h after onset of symptoms) and spontane-
ous. Several outbreaks have been associated with "slow cookers" or 
crockpots, or with casseroles which had not reached a high enough inter-
nal temperature to destroy the lectin. It has been shown that heating to 
80°C may increase the toxicity five-fold, so that these beans are more 
toxic than if eaten raw. In studies of casseroles cooked in slow cookers, 
internal temperatures often did not exceed 75°C (CFSAN, 1992). 
To avoid intoxication different cooking procedures have been recom-
mended. The Public Health Laboratory Services, Colindale, U.K. recom-
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mend the following procedure for kidney beans and other beans: Soak the 
beans in water for at least 5 hours, pour away the water and boil briskly 
in fresh water for at least 10 minutes. The Danish Food Agency, however, 
recommended in 1989 a longer soaking period (8 hours) and at least 45 
minutes boiling (Levnedsmiddelstyrelsen, 1990). 
4.5 Carambole (star fruit) 
Background: 
Averrhoa carambola L. (Carambole, Starfruit) was introduced in the EU 
a few decades ago. Carambole is an up to 10 m high tree belonging to the 
Oxalidaceae family, producing 8-12 cm long light to golden yellow fruits 
with five sharp ridges that form a characteristic star-shape when the fruit 
is cut in slices across the ridges. The form of these slices has given the 
fruit its trivial name ‘star fruit’. Although the plant originates from Cey-
lon and the Moluccas, it is nowadays grown in many other tropical and 
subtropical regions of the world.  
There are trees of two types. The first one is producing smaller and 
sourer fruits, which, however, are richly flavoured and contain higher 
levels of oxalic acid than the other type of tree. The second type is pro-
ducing larger and sweeter fruits that are mildly flavoured and contain less 
oxalic acid (Morton, 1987; Yang et al., 1995; Chen et al., 2001). Fruits of 
the sour type are rarely consumed fresh but used in the production of 
carambole juices. 
Health and safety issues: 
Since 1993 several investigators have reported intractable hiccups and/or 
severe neurological effects after ingestion of moderate quantities (half a 
fruit to ten fruits) of carambole fruit, or corresponding amounts of juice, 
in patients on a regular programme of haemodialysis (Martin et al., 1993; 
Moyses Neto et al., 1998, 2003; Chang et al., 2000, 2002; Tse et al., 
2003).  
The time from ingestion of carambole to onset of symptoms of intoxi-
cation has been reported to range from 0.5 to 14 h. The most common 
symptoms among the 32 patients of Moyses were persistent and intracta-
ble hiccups (94%), vomiting (69%), disturbed consciousness (66%), de-
creased muscle power, limb numbness, paresis, insomnia and paresthesias 
(41%), seizures (22%), and haemodynamic instability (9%) (Moyses 
Neto et al., 2003). A substantial percentage of affected patients died. 
As haemodialysis was a successful treatment of the intoxication, it 
seems likely that dialysis removes the toxic substance from the blood 
(Martin et al., 1993; Chang et al., 2002; Moyses Neto et al., 2003). It has 
been suggested that carambole contains a powerful neurotoxin that can 
accumulate in the blood and cross the blood-brain barrier in chronic renal 
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patients, and eventually cause irreversible damage (Moyses Neto et al., 
1998).  
Safety assessment: 
With two exceptions, all cases of carambole intoxication have occurred in 
persons with severe kidney failure, requiring haemodialysis. The two 
exceptions were seemingly healthy individuals that developed acute ox-
alate nephropathy (renal failure shown by blood chemistry and renal bi-
opsies) needing haemodialysis after ingestion of large quantities of juice 
(1.6 and 3.1 l, respectively) from sour carambole on an empty stomach 
(Chen et al., 2001). The authors suspected oxalic acid to be the toxic 
principle in the carambole as the cases had ingested approximately 13.1 
and 9.2 g oxalate, respectively. Oxalic acid and its soluble salts are poi-
sonous to humans and animals, whereas insoluble salts of calcium and 
magnesium oxalate are not (Sanz and Reig, 1992). Oxalates ingested by 
humans together with other foods may be precipitated by calcium as an 
insoluble complex, which then is excreted in faeces. The lethal dose of 
soluble oxalate varies from 2 to 30 g in humans (Beier, 1990). Support 
for their hypothesis were obtained in feeding studies of rats with normal 
oxalate containing and prepared oxalate-free carambole juice (Fang et al., 
2001; Chen et al., 2002). 
To avoid acute oxalate nephropathy, rarely observed in healthy indi-
viduals, it has been suggested that pure sour carambole juice should not 
be consumed in large quantities, especially on an empty stomach or in a 
dehydrated state (Chen et al., 2001).  
The hypothesis that oxalic acid is responsible for the neurotoxic ef-
fects of carambola in hemodialysis patients has been questioned, as it 
does not fit with oxalate exposure from other foods. Although rhubarbs, 
and plants such as curly dock (Halogeton glomeratus), containing similar 
amounts of oxalate to carambole, have caused acute oxalate nephropathy 
in humans as well as in animals (Panciera et al., 1990; Sanz and Reig, 
1992), no neurological effects similar to those induced by carambole in 
patients on haemodialysis have been reported. Furthermore, consumption 
of vegetables, such as spinach or beets, that also contain high levels of 
oxalate have never been reported to be associated with acute oxalate 
nephropathy.  It is of course possible that cooking may reduce oxalate 
absorption. In conclusion, at present the identity of the (neuro) toxin in 
carambole is unclear.  
4.6 Nangai or ngali nut 
Background: 
The Nangai, Ngali, Canarium nut (Canarium indicum L.) is a member of 
the Burseraceae family. The plant part used for human consumption is the 
 Risk Assessment and Risk Management of novel Foods 45 
kernel (almond) of the nut. The fruit has an outer fleshy mesocarp and a 
hard endocarp covering the kernel. The nuts are normally sold as “nut-in- 
shell” (with endocarp) or as “kernel-in-testa”(without endocarp) (Thom-
son and Evans, 2004). 
An application to put this product on the European market was sub-
mitted to the Competent Authority in France at the end of 1998. Accord-
ing to information from the novel food applicant, an average nut-in-shell 
weighs about 14 g (8-20 g). The nut-in-shell contains from one to three 
kernels (weight about 3 g each), which are the edible part from the tree. 
The nutrient profile of nangai nuts closely resembles that of nuts in gen-
eral. Thus, they are characterised by a high fat content, around 45 % with 
48.5% of the fatty acids being saturated, 38% being monounsaturated and 
14% being polyunsaturated (English et al., 1996, Thomson and Evans, 
2004). According to information from the applicant, the estimated con-
sumption of nangai nuts in Western Melanesia is about 60 tonnes of al-
monds or about 70 g/person/day. 
The nangai nuts were classified as novel foods within EU. The French 
authority that received the novel food application and performed the pri-
mary safety assessment gave a positive opinion on the application in 1999 
but suggested a conditioned approval. It was suggested that the approval 
should be conditioned regarding microbiological quality, regular monitor-
ing of aflatoxin levels and labelling requirements similar to those for nuts 
in general because of the potential risk for allergenicity. However, four 
member states raised objection to the primary assessment. In their view 
the applicant had failed to show that consumption of nangai nuts did not 
lead to toxicity. A safety concern was raised because of the lack of toxic-
ity data. The microbiological investigation of the indigenous flora of the 
nuts was found to be incomplete and therefore the product was found not 
to comply with the current EU hygiene standards. The Commission de-
cided to consult the Scientific Committee on Food for evaluation of the 
potential health concerns related to the food use of the product. They 
gave their opinion in 2000 (SCF 2000). 
Health and safety issues: 
Concern was raised against missing toxicity data, the potential allergenic-
ity of the nuts and their hygienic standard. 
Safety assessment: 
The Scientific Committee for Foods concluded that the information sub-
mitted to demonstrate the safety of the nangai nuts was incomplete with 
regard to the analytical procedures employed for determining their nutri-
tional composition and the extent of natural variation of the data submit-
ted (SCF 2000). Furthermore, the possible allergenicity of nangai nuts 
had not been investigated and adequate toxicological data were not avail-
able. Therefore, according to the assessment procedures laid down in EU 
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Regulation 258/97, Article 6.1 and in the Commission Recommendation 
of 29 July 1997 (97/618/EC) for the evaluation of the safety of novel 
foods, no conclusions could be drawn on the safety of consuming the 
nangai nuts.  
Two reports concerning the potential allergenicity of nangai nuts in 
humans not previously exposed to this nut have been published after the 
SCF expressed its opinion. One of these reports describes a possible 
cross-reactivity between nangai nuts and various tree nuts - pistachio, 
hazel nut and cashew nut (Frémont et al. 2001). The other report shows a 
possible IgE-cross-reactivity in patients suffering from grass, birch and 
mugwort pollen allergy (Sten et al., 2002).  
4.7 Noni Juice 
Background: 
Noni (Morinda citrifolia) is a small tree or shrub belonging to the family 
Rubiaceae and native to the region from south-eastern Asia to Australia. 
The tree produces a yellowish white, fleshy, 5-10 cm long fruit (the syn-
carp) (ca. 3-4 cm in diameter) that become soft and fetid when ripe. In 
Hawaii Noni was originally cultivated for its medicinal and dye proper-
ties, and has now become naturalised in relatively dry sites, at altitudes 0-
450 m. All parts of the plant are used, including roots and bark (dyes, 
medicine), trunks (firewood, tools), and leaves and fruits (food, medi-
cines). It is an important sources of traditional medicine in the South-East 
Asia (Tap and Bich 2003) The medicinal applications, both traditional 
and modern, span a vast array of conditions and illnesses, although the 
efficacy of most of these applications has yet to be scientifically sup-
ported. Noni has attained significant economic importance worldwide in 
recent years through a variety of health and cosmetic products. These 
include fruit juices as well as powders made from the fruits or leaves. 
Considering a request for placing pasteurised fruit drinks of the noni 
fruit (Morinda citrifolia) on the European market in 2000, the Belgian 
authority came to the conclusion that an additional assessment was re-
quired. This additional assessment was requested from the EU Scientific 
Committee on Food (SCF), which considered the product acceptable at 
intake levels up to 30 ml per day (SCF, 2002). 
The EU authorisation of Noni juice as a novel food ingredient dates to 
5 June 2003 and is limited to a particular product, juice of the noni fruit 
(Morinda citrifolia) produced by Morinda Inc, for use in pasteurised fruit 
drinks. No other producets of noni products, say jam, spray dried juice, or 
whole dried fruit, can use the authorisation unless evidence can be pre-
sented of substantial equivalence. 
The authorisation from the European Commission further stated that 
the SCF noted that the data supplied and other information available pro-
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vided no evidence for special health benefits of “Noni juice” which go 
beyond those of other fruit juices, and that Morinda Inc., therefore, might 
not sell the products as promoting health. 
Health and safety issues: 
SCF considered in 2002 the product acceptable at the suggested levels of 
intake, at most 30 ml per day (SCF 2002). The overall usage has increa-
sed considerably since then, and in 2005 three reports on acute hepatitis 
caused by Noni preparations have been published (Millonig et al., 2005; 
Stadlbauer et al., 2005).  
Safety assessment:  
SCF based its conclusion regarding the safety on the information about 
the chemical composition of the fruit juice, as well as the toxicity and 
allergenicity data supplied by the applicant. 
4.8 Cassava (Manihot esculenta Crantz) 
Background: 
Cassava is grown for its enlarged starch-filled roots, which contain about 
30% starch and very little protein. Cassava grows well in a tropical cli-
mate and is eaten primarily in Africa, Pacific Island Countries, South 
America and regions of Asia including Indonesia.  Cassava is consumed 
in a number of forms: flour used for cooking, root slices, root chips, 
baked grated root, steamed grated root, pan fried grated root, steamed 
whole root, and tapioca pearls made as a pudding.  Cassava contains a 
toxic, cyanogenic glycoside, linamarin, which break down upon disrup-
tion of the plant cells to form hydrogen cyanide (HCN). 
There are a number of varieties of cassava, each of which has a differ-
ent cyanide level.  Traditional uses of cassava as food are dependent on 
adequate processing prior to human consumption.  Values from 15-400 
mg/kg fresh weight of HCN in cassava roots have been reported in the 
literature.  Sweet varieties of cassava (low cyanide content) can be proc-
essed adequately by peeling and cooking (e.g. roasting, baking or boil-
ing), whereas bitter varieties of cassava (high cyanide content) require 
more extensive processing, involving techniques such as heap fermenta-
tion, which take several days.  Bitter varieties are not normally commer-
cially traded. 
Health and safety issues: 
If cassava is eaten raw or after inadequate processing, evidence of both 
acute and chronic toxicity, may be observed.  The symptoms of acute 
cyanide intoxication include rapid respiration, drop in blood pressure, 
rapid pulse, dizziness, headache, stomach pains, diarrhoea, vomiting, 
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mental confusion, twitching and convulsions.  In extreme cases, death 
due to cyanide poisoning may occur.  The chronic effects of cyanide in-
toxication are linked to regular long-term consumption in individuals 
with poor nutritional status and include: konzo, an upper motor neuron 
disease; tropical ataxic neuropathy, a term used to describe several neuro-
logical syndromes; and goitre and cretinism, which are caused by iodine 
deficiency and can be considerably aggravated by a continuous dietary 
cyanide exposure.   
Safety assessment: 
Ingested cyanide follows the known cyanide metabolic pathway and toxi-
cokinetics in humans whereby cyanide is detoxified by the enzyme rho-
danese, forming thiocyanate, which is excreted in the urine.  This detoxi-
fication requires sulphur donors, which are provided from dietary sulphur 
amino acids.  There are several factors influencing the hydrolysis of cya-
nogenic glycosides, and therefore, the overall toxicity. These include 
nutritional status, particularly with respect to protein, riboflavin, vitamin 
B12, sodium and methionine. 
The likelihood of cyanide intoxication from consumption of cassava is 
dependent on body weight and it is possible that a child or person of 
smaller body weight would not be able to detoxify the cyanide resultant 
from a meal of inadequately prepared cassava.  The acute lethal dose of 
HCN from human is reported to be 0.5-3.5 mg/kg b.w.  Approximately 
50-60 mg of free cyanide from cassava constitutes a lethal dose for an 
adult man. 
In populations where cassava does not have a tradition of use and 
where the community may not possess adequate knowledge regarding the 
risks of insufficient preparation, widespread use in the community would 
increase the public health risks. 
4.9 Conclusions on experiences from past and present 
cases 
The case stories confirm the old saying of Paracelsus that everything is 
poisonous, it only depends upon dosage. Most food items do carry inher-
ent safety problems of chemical nature, which eventually in accidental 
situations or due to wrong handling procedures may lead to acute or 
chronic disease situations. 
Consumers at the regional or local level or belonging to specific eth-
nical groups have learned by experience how to cope with negative char-
acteristics of their native foods either by avoiding them (allergenicity 
from kiwi or nuts), limiting intake of them (selecting for low alkaloid 
lupin seeds) or using special preparation procedures before eating them 
(soaking and cooking of red kidney beans), or by accepting the risk of 
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adverse health effects based upon a cultural risk/benefit tradition, where 
the benefit of availability of such foods counts heavily on the beneficial 
side of the equation (cassava). 
As illustrated in the cassava case (i.e., ”in populations where cassava 
does not have a tradition of use and where the community may not pos-
sess adequate knowledge regarding the risks of insufficient preparation, 
widespread use in the community would increase the public health 
risks”), novel plant foods may need special attention when introduced in 
countries and regions, where there is no tradition for their use.  
 
 5. Potential for new, novel plant 
foods to be introduced on the EU 
market. 
Present day global food supply has become increasingly dependent on 
only a handful of crops. More than 50% of the worldwide requirement for 
plant-derived proteins and calories are met by only three cereals: maize, 
wheat and rice. Thirty plant species used today meet 95 % of the world's 
total food energy supply coming from intake of plant foods (FAO, 1996). 
The production figures from these 30 food plants are given in table 1. 
Around 150 plant crops have a significant commercialisation on a global 
scale.  
Table 1.The world production figures of thirty major food crops taken from Faostat 
2004 (megatons) (Janick, 1999). 
 
Food group Species Production 
(megaton) 
Food group Species Production 
(megaton) 
Cereals Maize 638 Vegetables Tomato 113 
 Rice 589  Watermelon 91 
 Wheat 556  Cabbage 66 
 Barley 142  Onion 57 
 Sorghum  60  Bean 25 
 Millet  30 Fruits Bana-
na/Plantain 
102 
 Oat  26  Orange 60 
 Rye  15  Grapes 60 
Oil seeds and 
oil-legumes 
Soybean 189  Apple 58 
 Cottonseed 56  Mango 26 
 Coconut 53 Tubers Potato 311 
 Rapeseed 36  Cassava 189 
 Groundnut 36  Sweet potato 122 
 Sunflower 28  Yams 40 
Sugar crops Sugarcane 1 333    
 Sugar beet 234    
 
 
A number of other food plants are contributing to the last percentages of 
the daily plant food supply. The EU AIR project NETTOX, 1995-1997, 
compiled and evaluated data on natural food plant toxicants in the Euro-
pean food supply in order to assess the human health risk of consuming 
plants with such toxicants, and to identify strategies to minimize such 
risks (NETTOX 1998). For this purpose the NETTOX project produced a 
list containing all the food plants species, including spices (and mush-
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rooms), consumed in Europe in 1997. This list containing about 300 food 
plants was in 1997 agreed to be a comprehensive list of food plants from 
a European perspective by food experts from 15 European countries (the 
NETTOX list with English and Latin plant names is given in Annex 3). It 
seems unlikely that foods derived today from the edible parts of the 
NETTOX plants (as defined in the monographs of the list) would be con-
sidered as novel foods in a EU context. The NETTOX list is presently 
being updated in a new EU project EUROFIR in the light of EU being 
enlarged by the accession of 10 new Member States.  
Ethnobotanical surveys performed by the International Plant Genetic 
Resources Institute (IPGRI) indicate that across the world 7000 plant 
species are cultivated or harvested from the nature to complement the 
food supply (Wilson, 1992; IPGRI, 2004). This corresponds to approxi-
mately 10% of the estimated number of edible species present in nature 
(Myers, 1983). Below are given some examples of more specified lists of 
food plants developed in different contexts. 
IPGRI hosts a list (called NUS) on their web-site with examples on 
neglected and under-utilised crop species in different parts of the world. 
This list comprises about 100 plants, some of which would likely be con-
sidered novel fruits or vegetables in the European Union (Annex 1). 
Similarly, Hegarty et al. (2001) listed around 100 Australian bushfood 
plant species, which had been ingested by the aboriginals. For the great 
majority of the bushfoods examined, there are no reports on adverse ef-
fects following normal usage and intake despite enquiries in the commu-
nities where they are consumed. Although some of these plant foods may 
not be considered novel foods in an Australian/New Zealand context, 
they most likely would in a European context.  
A compilation from 1999 of useful Peruvian plants recognized 782 
edible plants species for that country alone (Brack Egg, 1999), and a 
global inventory of food crops listed several thousand edible species that 
are either cultivated or collected from the wild (Kunkel, 1984, Hermann, 
personal communication). These few examples illustrate that there are 
many plants that have a history of (safe) use as food in the regions where 
they grow but they would potentially be classified as novel foods if they 
were to be introduced onto the market in the European Community today. 
In view of the on-going general climatic and demographic changes, 
the need for alternative crops to meet these conditions may only be en-
countered through the introduction and utilisation of novel food crops and 
varieties of novel food crops selected from this extant crop biodiversity. 
Therefore a number of non-traditional plant food crops may become in-
troduced, not only in Europe, but also in the world market in the years to 
come, thereby underlining the need for introduction of generally agreed 
means and methods to assess the safety and the nutritional properties of 
the novel foods derived from such plants. 
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5.1 Conclusions on the potential for novel plant foods 
 to be introduced in Europe 
Around 30 food plants serve 95% of daily intake of plant food calories. In 
Europe the last percentages of the daily plant food are delivered by 
roughly 300 other plant species. Both the 30 and the 300 plants have the 
potential to deliver novel food items from plant parts which have not 
hitherto been used in the human food supply but the major potential sour-
ce for novel plant foods is the nearly 7000 other plant species used in the 
human food supply in other parts of the world.  
This report focuses on the situation when novel food items from these 
7000 plants are to enter the European market. 

 6. Assessment of novelty and 
safety of plant foods.  
Foods that are well known and traditional in one country or region may 
be unknown and thereby novel in another country or region. As exempli-
fied in chapter 4 the knowledge and the traditions developed in each 
country or region on how to handle the individual plant food item are of 
great importance for the safe use of it. Some of these traditions actually 
assist in preventing development of acute or chronic diseases which may 
be linked to too high intakes of that food item or to the intake of un-
prepared or wrongly prepared plant food.  
Today there is great interest in the introduction of novel foods many 
of them with health-promoting claims and often with the claims telling 
that they have a long history-of-use somewhere, far away. Some coun-
tries have developed legislation to prevent potential health or safety prob-
lems raised by the introduction of such products in their market. The leg-
islative approach taken usually builds upon a distinction between the 
traditional foods and the so-called novel foods in that country or region. 
The European, the Australian/New Zealand and the Canadian Novel 
Food Regulations are good examples. All demand a pre-market notifica-
tion or assessment and acceptance/approval of the novel foods, before the 
products are placed on the market. The EU, the Canadian and the Austra-
lia/New Zealand regulations all require that the determination that some-
thing is novel is the first step and considered distinct from the safety as-
sessment, which is second.  
Two main issues immediately come up with such a legislation: the 
first one is the challenge on how to determine if a food item is traditional 
or novel, and to decide on the degree of un-familiarity which makes the 
food item novel. The second challenge is to establish what kind and ex-
tent of safety data is needed to make a safety assessment of an acceptable 
sensitivity and predictability of such a novel plant food. Both challenges 
carry a strong scientific component, but in the end both are management 
decisions. 
The present chapter focuses firstly on general criteria defining novelty 
of exotic fruits and vegetables, and secondly on general criteria for as-
sessing their safety in use based on the present scientific experience in the 
field and building on the present managerial approaches taken. The over-
all approach suggested below consists of a proposal for a management 
procedure to separate novel plant foods from traditional plant foods and a 
proposal for a management based scientific assessment policy to establish 
the safety of those plant foods defined as novel foods.  
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This 2-step procedure complies with the approaches taken in the risk 
analysis process as described by FAO/WHO (1995, 1997), SSC (2000, 
2003 a, b) and NNT (Fabech et al., 2002). The separation of novel plant 
foods from traditional plant foods becomes part of the establishment of 
the risk profile, and the scientific assessment policy becomes identical to 
the management driven establishment of the risk assessment policy as the 
basis for the conduct of the risk assessment. 
6.1 Determination of novelty of the plant food as part of 
the establishment of a risk profile  
Risk profiling is the process of describing a food safety problem in its 
societal context in order to identify those elements of the risk and benefit 
relevant to various risk management decisions.  
The risk profile is based on available knowledge and is not a complete 
risk-benefit assessment but a first step. A typical risk-benefit profile 
includes the following: 
 
• A brief description of the situation 
• Products or commodities involved 
• Information on present intake/exposures 
• Values expected to be placed at risk, e.g. human health 
• Economic concerns 
• Potential consequences 
• Consumer perceptions of risks and benefits 
• The societal distribution of risks and benefits 
 
The decision, whether a plant food is novel (or not), will emerge from the 
discussion points listed above.  
The Working Group has looked at the information presented in the 
previous chapters regarding the variability of regulations introduced 
around the world, the historical experience, the potential for novel plant 
foods to be introduced on the European market in the future, and the ex-
amples on past and present introductions of novel plant foods in Europe.  
The Working Group recognised early that it is impossible to define the 
individual food item as a novel food for a country or a region from a 
purely scientific point of view and therefore encompassed the necessity 
of including the management perspective in the decision on the novelty of 
foods derived from plants. The history of (safe) consumption is already 
recognised as an important part of the background information necessary 
for this decision in EU, Canada and Australia New Zealand.  
The Working Group adopted the Australian/New Zealand approach to 
divide foods in traditional foods and non-traditional foods and let a subset 
of the latter be considered novel foods if there is insufficient knowledge 
 Risk Assessment and Risk Management of novel Foods 57 
in the broad community to enable safe use in the form or context in which 
it is presented, taking into account the composition or structure of the 
product, the levels of undesirable substances in the product, the known 
potential for adverse effects in humans, the traditional preparation and 
cooking methods, or the patterns and levels of consumption of the prod-
uct. The scientifically based information required to establish the risk-
benefit profile is a risk management tool influenced by societal values 
and traditions and leads to the conclusion on the novelty of the food in 
question. 
The Working Group looked at the possibilities for developing a more 
generic approach to the process of defining novelty based upon the in-
formation in chapter 5 on plant sources used for the global food supply. 
This approach was especially triggered by the information from FAO 
about the worldwide production of different crop plants for food purposes 
telling that a very limited number of food plants meet 95% of the world’s 
food energy needs from plants. Along the same line of thinking the EU-
AIR research project NETTOX identified 307 food plants in the human 
diet in the 15 Member States of the European Community in 1998. The 
idea with the NETTOX list was to include as a start at least all major 
plants (and mushrooms) used for human consumption in Europe. Since 
IPGRI at the same time has identified more than 7000 plant species as 
potential food sources, this demonstrate the future potential for many 
human populations to be presented for non-traditional or novel plant 
foods coming from plants they never have seen before in their area. This 
information also opens up the possibility to develop a more systematic 
approach to determine novelty based on the botanical identity of the food 
source. 
On this background the Working Group developed the decision tree 
presented in figure 1 with the aim to obtain a rational, logic and simple 
device for the identification of novel plant foods on a global, regional or 
local scale. The decision tree is developed to be used for foods from 
plants, both plant species, varieties and sub-varieties of plant species. 
Similarly the decision tree approach undoubtedly can be adapted to foods 
from mushrooms, microorganisms and animals (but this is outside the 
scope of the present report). 
The following definitions have been applied for this decision tree for 
the assessment of the novelty of food from conventional plants: 
 
• Plant foods: Products used as food with a plurality of chemical 
constituents in a complex, holistic interplay ranging from intact fruits 
and vegetables, over complex botanical products like flour and 
botanical extracts to oils, fibres and proteins. Distinct from pure 
chemicals with only one chemical entity as the building block. 
• Traditional foods: Foods with a history of significant human 
consumption by the broad community for several generations as part 
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of the ordinary diet and thereby generally recognised as safe at the 
global, regional or local level or by an ethnic group. 
• Non-traditional foods: Foods with no history of significant human 
consumption by the broad community for several generations as part 
of the ordinary diet. 
• Novel foods: Non-traditional foods for which there is insufficient 
knowledge in the broad community to ensure safe use, or which have 
characteristics that raise safety concerns due to composition, levels of 
undesirable substances, potential for adverse effects, traditional 
preparation and cooking, and patterns and levels of consumption. 
• Global list of traditional food plants: A list of plants, identifiable by 
name and delivering specified plant material used for traditional 
foods at the global level.  
• Regional lists of traditional food plants: A set of lists with plants 
delivering plant material used for traditional foods at the regional 
level covered by the individual list. “The Region” may be defined on 
the basis of the five regional dietary patterns described by 
WHO/FAO in GEMS (WHO, 2003): Middle Eastern, Far Eastern, 
African, Latin American and European (incl. Australia, Canada and 
the USA), or as economical or regulatory entities like EU or 
Australia/New Zealand. When finalised the lists should cover all 
geographical regions of the world, thereby supplementing each other. 
• Local lists of traditional food plants: Lists with plants delivering 
plant material used for traditional foods at the local level. A “Local 
lists” could cover EU, or individual nations like Denmark and China, 
or an area with a human population of mixed ethnic origin within a 
region or nation.  
• Ethnobotanical lists of traditional food plants: Individual lists with 
plants delivering plant material used for traditional foods by 
individual ethnical groups. “Ethnobotanical lists” are lists developed 
to cover well-established plant food eating habits of a defined ethnic 
entity, e.g. aboriginals in Australia.   
 
At the top of the Decision Tree in Figure 1 plant foods are divided into 
the traditional worldwide plant foods and plant foods with no worldwide 
tradition. Traditional plant foods at this level of the decision tree need no 
further assessment of their safety. They are by definition meant to be 
accepted regionally and locally all over the world. 
Non-traditional plant foods from the global level of the Decision Tree 
should then at the regional and local level be subdivided further into plant 
foods regionally and/or locally accepted as food and those not regionally 
and/or locally recognised as food. If a non-traditional plant food from the 
global level is accepted as food at the regional level, it implies that it is 
accepted also locally, while a locally accepted food still may be consid-
ered novel at the higher regional level.  
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For the purpose of understanding and evaluating the decision tree ap-
proach suggested in figure 1, two lists of plants have been prepared as 
preliminary examples. The first one appearing in Annex 2 is a modified 
FAO-list of plants (FAOSTAT 2004) with non-food items excluded. The-
se plants are worldwide recognised as food sources and can thus make the 
first prototype for a global list. It should be mentioned, however, that for 
some products on the FAO list it may not be clear whether they should be 
defined as food or not, like Areca Nuts (betel), that might be considered 
as food or medicine in different part of the world. For risk management 
purposes, therefore, a final global list of foods will need an international 
acceptance by risk managers.  
Figure 1. Decision tree approach for the identification of novel foods
from conventional plants for safety assessment
Non-traditional worldwide plant foods
Recognised as food in the actual
region or local level ?
Foods derived from conventional plants
Recognised worldwide as food?
No further
assessment foreseen
Fullfill criteria for being a novel food
to be assessed for safety on regional 
or local level. 
No further
assessment foreseen
on regional or
local level
Yes
No Yes
No
 
The second list in Annex 3 is the prototype for a regional or local list 
consisting of plants with no worldwide recognition as sources for major 
food items. Basically such a regional or local list as the one in Annex 3 
can be generated from a list of all food plants in the area by subtracting 
the plants from the modified FAO list in Annex 2. The list in Annex 3 is 
made in this way and represents the first prototype of a regional/local list 
covering food plants used in the EU in 1998 (NETTOX 1998) excluding 
the ones on the list in Annex 2. Altogether the food plants on the global 
list and the regional list make up the total number of food plant tradition-
ally used in that region. 
The use of lists such as FAO list (Annex 2) as a global list and the 
modified NETTOX list (Annex 3) as a regional or local list in the Decision 
Tree Approach in figure 1 immediately identifies differences in basic ap-
proaches and lack of information. The FAO list used as the basis for the 
global list in annex 2 is based on production figures and use common 
names for the plant items, and although most items like maize, rye, oats, 
brazil nuts, tomatoes, eggplants and carrots include only one species, many 
items on the list include more than one plant species. Examples of items, 
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which include a group of plants, are wheat (Triticum aestivum, T. durum 
and T. spelta), millets (7 or more different botanical small-grained cereal 
species) and beans (different Phaseolus and Vigna species). Therefore 
some of the plant species might only contribute to a very minor extent and 
have limited history of use. The NETTOX list in annex 3 on the other hand 
is based upon single plant species with Latin names but is still not compre-
hensive in covering all the known plant foods on the market in EU. 
However the lists give a good starting position for identification and 
eva
wi
onventional plants which 
ma
6.2 Establishment of a risk assessment policy for conduct 
The individual, scientific safety assessment needs to be preceded by a 
lishment of a risk assessment policy for novel plant foods 
starts with science where scientists in the field identify the safety data 
luation of exotic fruits and vegetables as sources for novel foods at the 
global, regional and local level of regulation. If the food plant lists are to 
be more useful or fitted for the evaluation of history of use, such lists 
should be based on single plant species with Latin names and include 
information on the plant part(s) normally used for consumption, recom-
mendations for preparation and cooking procedures would also be of 
value. For some plants even specification of the specific plant varieties 
may be of importance since for some species the varieties may differ a lot 
in relation to safe use (glycoalkaloid content in potatoes, lectins in beans). 
Foods derived from the plants included in the lists of Annex 2 and 3 
ll as a rule-of-thumb not be considered novel food in the EU region, 
unless parts not usually used as sources for food (as the stalk of wheat) 
are used in the production of food for humans. New food items derived 
from non-hitherto-consumed parts of traditional food plants will need 
further assessment at the scientific level based on scientific tools and 
scientific information described in chapter 7. The lists in annex 2 and 3 
could thus be the managerial starting point for the classification of food 
from conventional plants not on these lists as novel, meaning moving 
such food items to a formal safety assessment.  
It has not been possible to make a list of c
y deliver novel food from an EU point of view within the framework 
of this project, but as an example it can be mentioned IPGRI has made an 
inventory of native American fruits covering 1128 species, 285 genera 
and 66 families (IPGRI, 2005). 
of the scientific risk assessment 
general decision on a risk assessment policy in order to make the out-
come of the safety assessment accepted as the basis for the management 
decision regarding the unconditional acceptance of the novel food item 
on the market, its limited acceptance on the market or its rejection from 
the market.  
The estab
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nee
support to a management decision on 
ho
cribes the plant tissue(s) 
int
t, eliminating the possibility 
to 
safety and benefits of the novel plant food. The 
pro
ded to obtain different degrees of scientific sensitivity and specificity 
of the risk assessments and thereby predictability/reliability of their risk 
assessments. Afterwards it is a management decision on this basis to 
make a policy decision regarding the necessary availability of data e.g. in 
the form of a premarket data set.  
This section discusses the nature and the extent of scientific data that 
will be able to deliver scientific 
w to proceed based upon the questions raised in the risk profile regard-
ing safety and benefits of the novel plant food.  
The risk profile discussed in section 6.1 defines – at least provisional - 
the botanical identity of the source plant, des
ended for food use and identifies the gaps in readily available common 
and scientific knowledge which prevent the immediate establishment of 
safe use taking into account the composition or structure of the plant 
food, the levels of undesirable substances, the known potential for ad-
verse effects in humans, the traditional preparation and cooking methods 
and the patterns and levels of consumption. 
It is foreseeable though that many novel plant foods will have no ob-
vious defined target for the safety assessmen
immediately focus the whole safety assessment on one or few identi-
fied or known differences. Basically the safety assessment of complex 
novel foods from conventional plants is more complicated than the safety 
assessment of foods from GM plants because the novel food in principle 
is completely new in all traits, while the GM food normally only has been 
changed in one or few specific trait(s), which then can be the main focus 
of the safety assessment.  
The group, therefore, discussed the kind of a strategy to recommend 
for the characterisation of 
posed scheme is outlined in Figure 2. It builds upon the traditional 
elements in a safety assessment: hazard identification at the top (“Data 
from the Risk Profile”), the column at the right leading to characterisation 
of hazard and benefits, the column at the left leading to the exposure 
characterisation, and the combined use of the conclusions from those two 
columns to formulate the final risk characterisation, including its recom-
mendations for further actions to take. The full drawn arrows in Figure 2 
indicate the different paths, the case-by-case safety assessment can take 
depending on the case, while the dotted arrow underlines the iterative 
element in the assessment process, where new information and additional 
requests may make the process start over again.  
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Figure 2. Safety assessment of novel plant foods and novel plant food ingredients
Data from the Risk Profile
Human exposure scenarios History of use, incl. human experience
regarding safety and nutritional aspects
Human epidemiological data
Wholesomeness testing,
in vivo/in vitro
Chemical analysis/ omics
Characterisation of safety and benefits  
based upon ”the Margin-of-Exposure” approach.
Recommendations for further actions to take
Characterization of hazard and benefit  
(expected safe intake)
Exposure
characterisation
Preparation procedures
incl. cooking procedures
 
The starting point in the hazard characterisation process in the right col-
umn is the history of use, including human experience regarding safety 
and nutritional aspects. In many cases this information is available only 
on an informal basis, not in terms of formal scientific publications. De-
pending on the scientific quality of historical data a scientific characteri-
sation of hazards and benefits can be performed immediately, or the pro-
cess has to go through chemical analytical stage, through wholesomeness 
testing in vivo/in vitro, through production of human epidemiological 
data, as indicated in figure 2.  
The detailed approach of the safety assessment may differ between 
novel food items derived from plants already on the global list for recog-
nised food plants, plants on regional or local or ethnobotanical list(s) 
somewhere in the world, or plants never before approached for food use 
in any list. For novel foods derived from tissues of plants already on the 
global list, there are many sources of information regarding the presence 
of toxic or antinutritional substances in these food plants which may fa-
cilitate or direct the safety assessment. For plants on a regional or local 
list this may also be the case. For other plants, potentially useful in the 
food supply but not hitherto used as food to an extent that can justify 
them being on one of the regional lists, one of the local lists or in one of 
the ethnobotanical lists, only limited information may be available to 
guide the first steps in the safety assessment but the claims leading them 
to become candidates to be put in the category of food plants may give a 
lead. Also the history of previous use may be of great importance. 
The Working Group discussed whether it is possible to recommend a 
defined set of data requirements as a prerequisite for a safety assessment. 
An alternative could be a reiterated assessment after each step following 
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hierarchical data generation. In the end the Working Group decided to 
recommend a case-by-case approach as illustrated in figure 2 with the 
arrows pointing at the alternative pathways in the iterative safety assess-
ment process. The information needed to conclude the premarket assess-
ment may thus in some cases be the information from all the boxes in 
Figure 2, in other cases just information from some of them depending on 
the nature of the individual novel food. Typically the hazard characterisa-
tion will be concluded through a “weight-of-evidence” procedure, where 
both qualitative and quantitative aspects of the data findings count. The 
types of scientific information, which case-by-case form the basis for the 
hazard characterisation, are discussed in more details in chapter 7. 
A main discussion point during the process has been whether in 
vivo/in vitro safety testing should be performed as a mandatory segment 
of a premarket safety package or this data generation should only be 
made on a case-by-case basis. The group discussed the usefulness of the 
90-day rat feeding study as a “biological filter” adding safety assurance to 
the preceding boxes in the assessment scheme and agreed on its useful-
ness in this respect. Likewise the group discussed the need for formal 
epidemiological data in each case. In the end the NNT concluded that the 
degree of safety assurance required or expected by the society is a socie-
tal and moral issue and therefore the implementation of mandatory ani-
mal safety studies and/or formal human epidemiological data in a fixed 
premarket data package is a management decision to be taken in the po-
litical system. 
Regarding the human exposure scenarios, the NNT discussed the ex-
pected use or intake of the novel food based on its use as a bulk food for 
calories and major nutrients for daily intake or a less bulky source for 
flavours and micronutrients for only occasional use, the influence of 
preparation and cooking procedures, and the potential for use of probabil-
istic methods for calculation of intake.  
For the final safety/benefit characterisation the Nordic Group agreed 
not to recommend the use of safety (or uncertainty) factors. Instead the 
NNT advocates to characterise the safety and potential benefits simply by 
calculating the Margin-of-Exposure (MoE) as the relation between the 
safe level of intake determined in the hazard/benefit characterisation, and 
the actual estimated exposure in humans calculated from intake scenarios 
foreseen in exposure characterisation.  
Another management decision is whether to place the value for the 
MoE on a label of the novel food when it is marketed. When communi-
cated to the consumer on the label together with the information on how 
to prepare this novel plant food for eating, the value of the MoE will al-
low each user group to decide on the composition of the diet which fit 
him or her best in terms of securing him or her the most safe diet, the 
most nutritious diet or the most health promotional diet, or just a diet 
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which complies with his or hers personal values or expectation for good 
food.  
6.3 Conclusions on the assessment of novelty and safety 
This chapter recommends the division of plant foods in those accepted on 
a worldwide level, and in those considered non-traditional at a worldwide 
level. Many of those plant foods considered non-traditional on a world-
wide level might be considered traditional foods on a regional level in 
one or more regions, while they remain non-traditional as food sources in 
the other regions and therefore may be considered novel there. Likewise 
those remaining non-traditional at the regional level might be considered 
traditional at the local level within the region, or being traditional for 
ethnic group within the region or the local level. 
The first step of such a process will be to assess the novelty of the 
food through the establishment of a risk profile, and afterwards as a sec-
ond step assess the safety of the novel food going through a risk charac-
terisation procedure. Each step follows a separate decision tree approach.  
For the assessment of novelty at the first step this chapter recommends 
the development of a set of positive lists containing the plants accepted as 
sources of food either on the global level or on the regional/local level or 
by special ethnic groups. The global list, and the cluster of regional, local 
and ethnobotanical lists will – when developed - present the overall hu-
man experience with plant foods. When a plant food for the first time is 
going to be assessed for novelty on a regional or local basis, the other 
regional, local and ethnobotanical positive lists can be visited to see if 
this newcomer on the food market really raises new questions or it can be 
considered acceptable based on its usage elsewhere. 
The assessment of safety at the second step for those plant foods con-
sidered novel at the global, regional or local level the history of use is the 
first crucial element. The quality and quantity of the scientific data for the 
individual plant food in the databases behind the global, regional, local 
and ethnobotanical lists determines whether the history of safe use can be 
established immediately and a risk assessment concluded, or additional 
animal data, in-vitro data, human data and/or intake data is needed to the 
establishment of safety of this novel food based on its Margin-of-
Exposure. The tools needed for this assessment is described in the next 
chapter. 
 7. Different tools applicable for 
premarket analysis  
Both the European and the Australian/New Zealand Novel Food Regula-
tions demand a pre-market notification or assessment and accep-
tance/approval of exotic fruits and vegetables (if they are considered no-
vel in accordance with the relevant definition) before the products are 
placed on the market. The intention of the pre-market notification is to 
give the relevant authority the possibility to assess the potential risks of 
using the suggested novel food.   
The aim of the premarket assessment of novel foods is to demonstrate 
that the novel food is as safe as traditional counterparts or food items to 
be replaced in the diet by the introduction of this novel food and as such 
does not introduce any additional or new risks to the health of the con-
sumer (Howlett et al., 2003; Cellini et al., 2004). 
Most of the foods commonly eaten have never been investigated sys-
tematically with respect to their impact on consumer health. Generally, 
they are considered as safe unless a significant risk has been identified in 
humans. However, it should be emphasised that the absence of evidence 
of toxicity is not the same as evidence of safety. Without specific investi-
gations, only acute and severe adverse effects are likely to be identified. 
The demonstration of the safety of a food as part of the overall diet re-
quires specific intake information together with data on health impact. 
Although case reports, epidemiological observations, and/or experimental 
human studies may exist for a restricted number of foods (e.g. coffee), 
this type of information related to human health is lacking for most food 
plants (Schilter et al, 2003). 
The nature and extent of the toxicological data set required to assess 
the potential risk associated with a novel food depends largely on the 
nature of the novel food. Obviously, a plant that has never been con-
sumed before will put another challenge for the risk assessor than a novel 
food very much resembling a traditional food we have a long experience 
of consuming without health problems. 
There are many factors of importance when assessing the safety of 
novel foods. Howlett and co-workers (2003) stressed the fact that the first 
step in any safety assessment of novel foods comprises the collation and 
in-depth appraisal of information on the origin of the food material, pro-
duction, composition, nutritional characteristics, history of previous hu-
man exposure and anticipated use of the material, including required 
cooking procedures. This exercise should give a considerable amount of 
data that may allow a primary evaluation prior to initiating testing for 
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toxicity and other end points, and may in some cases be sufficient to 
permit a conclusion as to safety. This could, for example, be the case for 
exotic fruits and vegetables that have a vast history of safe consumption 
outside the European Community. In other cases it may serve to charac-
terise the novel food and to identify knowledge gaps and likely areas of 
concern. It should also provide a basis to define the extent and objectives 
of any additional studies that will have significance for the safety assess-
ment (Howlett et al., 2003). Additional information required could be 
data from toxicity studies in animals, toxicity of any related substances or 
foods, and any known cases of adverse effects in humans (FSANZ, 
2004). 
This chapter describes some of the main tools, which are applicable 
for the safety assessment of exotic fruits and vegetables prior to market-
ing. 
7.1 Characterisation of a plant food 
The precise specification of the plant food both from a botanical and 
chemical point of view is the most important template for trustworthy risk 
assessment.  
7.1.1 Botanical characterisation 
With regard to exotic fruits and vegetables and their products, which have 
not earlier been consumed to a significant degree within a region, a com-
plete scientific taxonomic identification will considerably speed up the 
identification of possible close relatives to the plant in question, thereby 
facilitating a prediction of chemical composition and an assessment of 
safety and the nutritional aspects.  
Taxonomic identity of the plant should be given according to interna-
tionally accepted principles, including complete scientific name (family 
name, genus, species, author name, subspecies, cultivar/breeding line) 
and common name (König et al., 2004). The sexually compatible wild 
relatives and their habitats have to be described. 
One example to demonstrate the necessity of giving extensive infor-
mation about the identity of a plant is that all known cabbages, whether 
red cabbage, Chinese cabbage, pak choi, Brussels sprouts or broccoli 
belong to the same species Brassica oleracea. One group of chemical 
constituents of Brassicas, the glucosinolates, has been claimed to give 
rise to adverse as well as health promoting effects. The glucosinolate 
composition and not least the concentrations vary considerably from one 
cultivar to the other. Also within cultivars the level of glucosinolates 
produced may differ e.g. influenced by several environmental factors, 
including growing conditions. 
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Another example would be a species where ‘ecotypes’ occur and these 
differ with regard to chemical composition. Although not being a likely 
candidate as food plant, the woody nightshade (Solanum dulcamara) 
could stand as an example. Depending on where in Europe samples of 
this species are collected the likelihood of collecting a plant with a par-
ticular composition of glycoalkaloids change (Andersson, 1999). 
It is also important to give information about what part of the plant is 
intended for food use. The chemical composition often varies substan-
tially between different plant parts. For many food plants only a single 
plant part is consumed and only that part of the plant is considered safe to 
eat, e.g. tubers of the potato plant (Solanum tuberosum L.). 
Additional information to aid the risk assessment could be whether the 
novel food is collected from nature or the plant is bred in a specific way. 
If agricultural practices are important, these should be adequately de-
scribed. 
The importance of correct botanical characterisation is underlined by 
the problems of mis-identification e.g. the intoxication caused by using 
Japanese star anise or bastard anise (Illicium anisatum L.) instead of the 
normally used spice Chinese star anise (Illicium verum L.) in a herbal tea 
in the Netherlands (Johanns et al., 2002). 
On the top of its botanical identity the individual varieties of the fruits 
and vegetables are characterised by their appearance, size, shape, colour, 
texture, smell and taste. These parameters are of great importance for the 
plant breeders, because these parameters also are determinants of the 
success of the products with the consumers. 
7.1.2 Chemical characterisation 
In most cases each cultivar is delivering one kind of food, a vegetable, a 
fruit, a grain etc., and this plant food is nutritionally characterized by its 
content of macronutrients, like protein, fats and carbohydrates, fibres, and 
micronutrients, like vitamins and minerals. The chemical characterization 
may be further specified by information on the content of specific pro-
teins, individual amino acids, fraction of oils, individual fatty acids, sim-
ple and complex carbohydrate, individual sugars and fibres.  
The chemical characterization of the plant food both from a regulatory 
point of view and a consumer point of view is most perfectly performed 
in the OECD Consensus Documents, specifically developed to character-
ize individual plant food items. An extract of the foreword of the OECD 
Consensus Document on Compositional Considerations for New Varie-
ties of Maize (Zea Mays) exemplifies this (OECD, 2002): 
 
 “These consensus documents contain information for use during the regulatory 
assessment of a particular food/feed product. In the area of food and feed safety, 
consensus documents are being published on the nutrients, anti-nutrients or toxi-
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cants, information of its use as a food/feed and other relevant information. This 
consensus document addresses compositional considerations for new varieties of 
maize by identifying the key food and feed nutrients, anti-nutrients and secondary 
plant metabolites. A general description of these components is provided. Also in-
cluded are considerations to be taken when assessing new maize varieties, includ-
ing suggested analyses.”  
 
And further in the preamble: 
 
“These data are used to identify similarities and differences following a compara-
tive approach as part of a food and feed safety assessment. They should be useful 
to the development of guidelines, both national and international and to encourage 
information sharing among OECD Member countries.”  
 
These documents present an excellent background material also for the 
development of the plant food lists recommended in this report (See 
chapter 6). 
Seen from a plant perspective the chemical constituents of plants can 
arbitrarily be divided into two classes according to function. Those 
known as primary plant metabolites are forming building structures and 
internal transport systems in the plants or contributing to the energy pro-
duction in the plants. The secondary metabolites are not essential to the 
basic metabolism of plants. They are formed from the primary metabo-
lites and occur in many different chemical forms often specific to a single 
species or a group of related species, and sometimes as a response to an 
inducer, e.g. a specific environmental condition or an infection or as a 
response to attacking insects. For a long time the function of most secon-
dary metabolites have been poorly understood. However, our understand-
ing of their role in the plants has increased during later years. Many sec-
ondary metabolites have a role in the plants defence machinery, others 
may be involved in metabolic processes or be created as by-products in 
these processes (Hegarty et al., 2001). Because of these roles of primary 
and secondary metabolites in the plants, primary metabolites are most 
likely to have nutritional importance in the consumer, whereas secondary 
metabolites are relatively more likely to give rise to adverse effects and to 
the flavours. 
An example of a systematic evaluation of consumed plants could be 
the study of Hegarty and co-workers (2001). These investigators under-
took a study of secondary metabolites in Australian bushfoods, assuming 
these constituents have the strongest potential for toxicity due to the Aus-
tralian diet. In this study they screened for the presence/absence of alka-
loids, cyanogens, oxalates and saponins in fresh and frozen samples of 
the major bushfood species, and determined the amounts of these com-
pounds present in the foods. The aim of the study was to broaden the 
knowledge about the chemistry of native plant foods, describe their his-
tory of use in the traditional communities, explore the potential to use 
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these foods as a resource for commercial exploration, as well as to indi-
cate areas where further research is required.  
It is obvious that knowledge is required on the types and amounts of 
nutrients and non-nutrients (primarily primary metabolites), vitamins, and 
minerals present in a novel food. In addition information is needed on the 
presence of potential anti-nutrients and natural toxicants. It might also be 
necessary to identify if the plant is particularly prone to become enriched 
by minerals and environmental pollutants, as for example selenium and 
heavy metals, respectively. If knowledge is scarce about the plant species 
in question, it has been suggested that information on the presence of 
natural toxins and allergens in related plant species may be used as guid-
ance for identification of classes of compounds most likely to occur in the 
investigated species (Howlett et al., 2003). If concern with respect to 
safety of a novel fruit or vegetable has been raised on such a basis, che-
mical analyses should form the core information on which to base the 
decision on the kind of further action to take e.g. performance of toxico-
logical investigations. 
This hierarchical approach has been taken in the EU AIR project 
NETTOX, 1995-1997, which compiled and evaluated data on natural 
food plant toxicants in the European food supply in order to assess the 
human health risk of consuming plants with such toxicants, and to iden-
tify strategies to minimize such risks (NETTOX, 1998). Due to variation 
in the quality of the compositional data and the safety data NETTOX had 
to develop a data quality assessment system, which graded the composi-
tional data in three classes and the toxicological data in four classes based 
on their scientific quality. Furthermore the LanguaL food description 
system was taken on board to enhance the compatibility between the 
NETTOX data and the national food consumption databases and thereby 
facilitate the risk assessment based upon hazard and exposure (NETTOX, 
1998).  
A situation that might pertain particularly often to novel foods is that 
chemical analytical standards for specific compounds are not available 
and, therefore, require chemical synthesis, which may substantially in-
crease the cost of the analytical exercise but may also produce material 
required for subsequent toxicity testing. If an extensive chemical analysis 
does not identify compounds that would trigger additional studies, this 
type of information may be the only data that are needed for the hazard 
characterisation (See figure 2). An example could be a novel food made 
from a plant part not previously consumed from an otherwise well estab-
lished plant food. 
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7.2 History of use as food 
Describing the history of use as food of a novel plant food is an important 
introductory part of the safety assessment. In a specific region the history 
of use as food of exotic fruits and vegetables varies from foods from 
plants that have never been consumed before, to plant foods that are well 
known from other regions and with a long history of use and no reported 
negative effects. 
Therefore the novelty of food plants is determined by the lack of an 
established documented history of use as food in a specified geographical 
region. For the determination of novelty in this respect the lists discussed 
in chapter 5 are of crucial importance. These positive lists with plants 
having a history of use as food can only be established based upon global, 
regional, and local efforts resulting in the establishment of lists, preferen-
tially based on databases documenting the claim that the particular plant 
food with its botanical and chemical identity has a history of use as food 
in the particular regional or local environment. Every list is to be defined 
by the geographical area it covers. When a plant food is presented as 
novel in a region, it may be followed by the information on history of use 
as food in another region taken from that regions positive list. 
The term “history of use as food” covers a description of the use in 
different defined geographical areas with information on intake levels, 
intake patterns, years on the market, different preparation and handling 
methods and impact on human health, while the term “history of safe use 
as food” includes a scientific evaluation of the information and implies 
that this evaluation can lead to a conclusion about its safe use.  
When using the term “history of safe use as food” for the conclusion 
rather than “history of use as food”, it may be defined as follows: 
“History of safe use” for a food is a term for the qualified presumption of safety, 
where there is evidence for its safety from compositional data and from experi-
ence as an ongoing part of the diet for a number of generations in a large, geneti-
cally diverse population. This presumption is for a certain context of use (condi-
tions of use, such as part of the plant used and required processing) and allows for 
minor population predispositions such as intolerance and allergenicity (S.Page, 
WHO: personal communication 2005). 
 
Instead of history of use the term “traditional use” has been suggested. 
The concept “traditional use” is based upon knowledge and experience in 
the heritage of a population/culture (but may have very limited scientific 
documentation), while well-established use in general is based on tradi-
tional use supplemented with available scientific data (Bast et al., 2002). 
Traditional use may provide information on acute toxicity but is unlikely 
to provide information on chronic toxicity. Information from traditional 
use will also be influenced by the availability of food, the general health 
of a particular population, and the available health care and health moni-
toring facilities (Bast et al., 2002). 
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In addressing the history of safe use, history of use, traditional use, 
and well-established use of plant-derived foods, a description of the novel 
food together with information respecting its development, details of 
major change(s), if any, details of the method by which it is manufac-
tured, prepared, preserved, packaged and stored, information regarding its 
intended use and directions for its preparation, information respecting its 
history of use elsewhere, and if applicable, information relied on to estab-
lish that the novel food is safe for consumption and information regarding 
the estimated levels of consumption by consumers of the novel food. The 
safe use of plant foods sometimes depends on special pre-treatment estab-
lished by “custom and practice” that renders it palatable and safe (König 
et al., 2004). This situation is illustrated by the red kidney bean example 
and to some extent the lupin example in chapter 4. 
In the description of history of use it is important to remember the 
context in which the history of use is developed, namely on the back-
ground of the traditional dietary pattern in the region. From a regulatory 
point of view, a region would appropriately be defined by country or 
community borders e.g. EU, but it could also be defined as WHO does in 
the Global Environment Monitoring System - Food Contamination Moni-
toring and Assessment Programme (GEMS/Food) (WHO 2003), where 
the global dietary patterns have been limited to five regional dietary pat-
terns, namely the Middle Eastern, the Far Eastern, the African, the Latin 
American, and the European pattern. The “European” diet includes non-
European countries with European-type diets, such as Australia, Canada 
and the USA. The GEMS/Food document lists about 250 raw and semi-
processed food items of both plant and animal origin with average per 
capita food consumption for each of the five regions. Furthermore by 
using a cluster analysis approach, thirteen GEMS/Food Consumption 
Cluster Diets have been produced based on FAO Food Balance Sheets 
(http://www.who.int/foodsafety/chem/gems/en/print.html).Although these 
diets were developed with the purpose to predict the dietary exposure to 
radionuclide contamination and have been used by the Joint FAO/WHO 
Expert Committees for evaluating food additives or pesticides residues, 
these GEMS diets could equally be used to define regions and to develop 
regional positive lists for plant foods with their individual history of use, 
consumption pattern or expected intake level. 
Additional important data to support a conclusion on a history of safe 
use of a novel plant food being a traditional food in other parts of the 
world could be information on serving sizes/daily intake levels, purpose 
of consumption, possible target population(s), and known potential prob-
lems (precautions, contraindications, adverse effects) (ILSI, 2003). As far 
as possible, published data should be collected and evaluated for their 
quality and usefulness at the regional or local level, because the na-
tional/regional literature in national/regional languages may contain a 
wealth of information not accessible via global data banks. It is extremely 
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important if such data could be inserted in databases developed to support 
the regional or local positive lists suggested to be developed for the food 
plants. This also means that the pre-existence of such plant lists in a re-
gion will be able to support applicants who wants to introduce such a 
plant food in a region, where it appears to be considered a novel food. 
Other sources, including data collection on site, may also be helpful to 
provide facts and/or guidance for the assessment (Howlett et al., 2003).  
Also of importance when addressing the history of use of a plant food 
is to take into consideration that traditional breeding constantly may bring 
different varieties of a food plant to the market. The food derived from 
such varieties may vary a lot in composition, and information covering 
the history of use for these different varieties are strongly needed to fa-
cilitate the process of establishing a history of safe use. 
Information on local claims or perception of any health effects con-
nected to the plant food may be of great help in assessing its safety. A 
plant that previously has been used for medicinal purposes or has a folk 
remedy reputation in various parts of the world, whether or not consumed 
as food (or botanical products/extracts covered by the definition of food), 
may have some physiological effects on health that need to be considered 
not only as beneficial but also from a safety point of view (Schilter et al., 
2003). 
Most of the exotic fruits and vegetables considered novel in one re-
gion might be well known with a history of use, even safe use, in another 
region. On this background the concept of positive lists for global, re-
gional, local and ethnobotanical food plants is introduced in chapter 6. 
Such a positive list shall describe the individual plant food and iden-
tify the source plant. Most appropriate the lists are based on the name of 
the food plant, which is then subdivided into the individual plant foods 
derived from that plant. The description shall include the plant names and 
synonyms for exact identification (including language equivalents from 
different parts of the World and the standardized names from the Interna-
tional Standards, ISO), specific plant part(s) analysed and the analytical 
results, sample size, year of sampling. It should also include description 
of maturity, cultivar, growing conditions, storage conditions, usual proc-
essing and food preparation procedures, country of origin, region of ori-
gin, season of harvesting. The compositional data of the edible parts shall 
contain information regarding macro- and micronutrients, inherent toxi-
cants and antinutrients. The individual plant monograph should also con-
tain references to the scientific literature covering nutritional, toxicologi-
cal and health promotional appraisal. When such lists have been estab-
lished world wide for each region or each national or economical 
community, which fit the best, everyone can take the advantage of the 
lists of each other for the assessment first of the novelty, and later of the 
safety of the different plant foods. The lists are foreseen to facilitate the 
global trade with exotic plant foods, and the regional and local accep-
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tance – and thereby introduction - of regionally novel plant foods, which 
turn out to have a history of safe use in other regions. 
7.3 Animal studies in the safety testing of novel plant 
foods 
Toxicological studies in experimental animals have historically been 
developed for assessing discrete chemical substances. Experimental stud-
ies on rodents are indispensable in the testing battery for safety assess-
ment of compounds such as food additives, pesticides, pharmaceuticals 
and industrial chemicals (WHO, 1987, 1999). Therefore, there are inter-
nationally accepted standard approaches for such tests (OECD 1995). In 
most cases, the test substance is well characterised, of known purity, of 
no nutritional value and human exposure is generally low. It is therefore 
relatively straightforward to feed such compounds to animals at a range 
of doses, some several orders of magnitude greater than the expected 
human exposure levels, in order to identify any potential adverse effects 
of importance to humans. When an adverse non-cancer effect has been 
identified, the animal study allows the establishment of the highest expo-
sure level at which no overt toxicity occur, the so-called No-Observed-
Adverse-Effect-Level or NOAEL (WHO, 1987 and 1999; ACNFP, 1999; 
Howlett et al. 2003). The NOAEL is subsequently used to calculate the 
safe level of intake, the Acceptable-Daily-Intake or ADI. 
In contrast, novel foods from plants are usually complex mixtures of 
various compounds, many with the potential to vary in concentration in 
the individual plant food depending on the plant variety used and the 
growth conditions. Due to the bulky nature of the food itself and the ef-
fect on satiety whole foods can only be fed to animals at low multiples of 
the amounts that might be present in the human diet. Toxic compounds 
embedded in the novel food may therefore never reach a level in animal 
studies at which the toxic potential of a constituent is revealed. In addi-
tion, a key factor to consider in conducting animal studies on foods is the 
nutritional composition of the feed. Increasing the fraction of the tested 
food in the feed above a particular level may distort the nutritional bal-
ance of the diet, and might induce adverse effects which are not related 
directly to the material itself but to induced nutritional imbalance. Picking 
up any potential adverse effects and relating these conclusively to an 
individual characteristic of the food can therefore be extremely difficult, 
unless the studies are well designed with the animal diets well adjusted 
(ACNFP, 1999; Dybing et al. 2002; Knudsen and Poulsen, 2005). A sen-
sitive and specific approach is to combine the testing of individual, piv-
otal compound(s) identified in the novel food with the testing of the 
whole food, eventually spiked with the pivotal compound(s), in separate 
studies (Knudsen and Poulsen, 2005). 
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The objective of any toxicity testing programmes for novel foods 
should contribute to the identification of a potential hazard, its dose-
response relationship, and the establishment of a reasonable certainty that 
no harm will result from its intended use as food (Howlett et al., 2003). If 
applicable, the safety of the novel product should always be compared 
with the safety of the foods it will replace (Howlett et al., 2003). Select-
ing the battery of tests required to establish the safety of novel foods has 
to be done case-by-case, not least because of the huge variation possible 
in the extent of novelty of the novel food as compared to traditional 
foods. Therefore, it is not possible to set general rules specifying a defini-
tive list of studies either for single defined substances or for whole foods. 
In deciding which studies are necessary and appropriate for a particular 
novel food the guiding principle should be that the studies address aspects 
of toxicity not addressed elsewhere by the information already available 
and that they are capable of doing so in an unambiguous fashion. The 
task to identify suitable toxicity studies may sometimes be very difficult. 
If the toxicity studies are not designed and undertaken with clear and 
achievable objectives in mind, it is unlikely that they will contribute posi-
tively to the safety assessment (Howlett et al., 2003). 
Considerations regarding the need for doing animal toxicity studies on 
the novel plant food in the premarket situation will most likely focus on 
two main issues: potential toxicity of inherent chemical entities of un-
known nature identified in the novel food and the safety of the whole 
food understood as the absence of adverse effects in a repeated dose feed-
ing study in rodents or pigs. 
The toxicity testing of distinct chemical entities of course depends 
upon the availability of those chemicals in isolated form to be mixed in 
the animal feed. Such a testing procedure will normally start with an acu-
te toxicity testing followed by a 28-day rodent feeding study (Knudsen 
and Poulsen, 2005). In practice, if toxicokinetic studies are to be done, 
they will only be possible for defined chemicals and simple mixtures and 
are not useful for complete foods, unless it focuses on a defined constitu-
ent (Howlett et al., 2003). 
In cases where a repeated dose animal feeding study on the whole 
food is likely to provide useful information in the premarket situation, a 
90-day subchronic toxicity study in a rodent species is likely to be a study 
of minimum reasonable duration, and may often be of sufficient duration 
to provide data adequate for use in evaluating safety or to determine 
whether there is need for further studies. The scope of the animal toxicity 
study should normally be to include the full range of experimental pa-
rameters appropriate for this type of protocol (Howlett et al., 2003). To 
ensure the scientific validity of such a rodent study, great attention and 
focus should be devoted to the design of the diet imbedding the novel 
food (Knudsen and Poulsen, 2005). It is suggested that a 90-day study in 
pigs may provide a better biological filter in the safeguard of human 
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health due to the more humanlike design of the gastrointestinal tract in 
this animal (S. Page, WHO, personal communication). 
A main challenge in the optimal design of repeated dose animal feed-
ing studies for the safety assessment is the identification of appropriate 
comparators to the novel foods for the control group. In some cases the 
choice is straightforward with the selection of fruits or vegetables closely 
related to the novel ones. In other cases the comparator may be the food 
item, which is going to be replaced in the human diet by the novel food. 
Finally in some cases no comparator can be identified and the novel food 
has to be assessed on its own. This may be the case for many novel foods 
where it is not clear what specific food or group of food it will replace. 
The levels of the novel food to be incorporated in the animal diet may 
either be one level, namely the highest level tolerated (calculated from a 
short-term study and the compositional data) when there is a good com-
parator, or two levels, namely comparable to expected human intake plus 
the highest level tolerated, when there is no comparator. In the first case 
the good comparator allows direct calculation of the Margin-of-Exposure 
between the novel plant food and the known (safe) intake of the compara-
tor, while the calculation in the second case depends upon the existence 
of experimental data illustrating that the expected human intake is safe 
(within the remit of the study). 
If the repeated dose feeding study becomes the pivotal study for the 
hazard characterisation, the dose level(s) used will be the one to compare 
with the expected human intake established in the exposure characterisa-
tion. The Margin-of-Exposure established in this manner then becomes 
the basis for the risk characterisation. 
7.4 Testing of novel foods in in vitro tests for toxicity and 
mutagenicity 
In vitro methods are relatively cheap and have a high throughput. How-
ever, results from in vitro tests may only be indicative of toxic effects as 
these test systems rely on reconstituted purified proteins or cell compo-
nents, or immortalised cell lines cultured artificially. They are only to a 
limited extent representative of the functioning of such cell components 
or cells in living organisms. In vivo tests are therefore required to confirm 
observations on absence or presence of toxic activity from in vitro tests 
(König et al., 2004). 
In vitro genotoxicity studies will often be useful only for defined 
chemicals or simple mixtures. In general, the testing of whole food ex-
tracts in genotoxicity studies is inappropriate as the experimental condi-
tion is likely to result in artefacts making interpretation difficult. Based 
on knowledge from the literature, however, single components of com-
plex novel foods may be identified and could be investigated in such 
76 Risk Assessment and Risk Management of novel Foods 
studies. For complex foods, some assurance of the absence of a potential 
for genotoxicity may be gained by appropriate "directed" investigations 
of bone marrow cells or peripheral lymphocytes undertaken as an addi-
tional complementary element of repeated feeding studies in rodents 
(Howlett et al., 2003).  
In the context of novel foods, it should be recognised that many bo-
tanical materials contain naturally occurring compounds that may test 
positive in genotoxicity tests in vitro. Although such results are indicative 
of that botanical material having a genotoxic effect, this might not neces-
sarily be the case. Most compounds that have turned out positive in in 
vitro tests have been negative in in vivo assays performed to confirm that 
mutations are induced also during this condition (Bast et al., 2002). Posi-
tive in vitro results should, however, be investigated with in vivo studies, 
unless the positive result can be attributed to an identified component 
known to be safe in vivo (EMEA Ad hoc Working Group on Herbal Me-
dicinal Products, 1999). 
7.5 Test of novel foods for allergenicity 
Food allergies are adverse reactions to otherwise harmless food or food 
components characterized by a response of the body’s immune system to 
specific protein(s) in foods (WHO/FAO, 2001). This response could be 
looked upon as abnormal, as only a minor fraction of the population (with 
disposition) would react in this way to the protein. The prevalence of 
food allergy in the Western world is up to 8% in children but only 2% in 
adults (Sampson and Burks 1996). Although food allergy is 3.6 times 
more frequent in children compared to adults it is confirmed that there is 
a preponderance of severe cases in adults (Morisset et al., 2003). 
The most common type of food allergy is mediated by allergen-
specific immunoglobulin E (IgE) antibodies. IgE-mediated reactions are 
known as immediate hypersensitivity reactions because symptoms occur 
within minutes to a few hours after ingestion of the offending food. IgE-
mediated reactions may occur to pollens, mould spores, animal dander, 
insect venoms and other environmental stimuli as well as to foods. In 
IgE-mediated food allergies, exposure to a specific food and its proteins 
in addition to reacting with antibodies elicits further development of food 
allergen-specific IgE antibodies.  
True food allergies also encompass delayed hypersensitivity reactions 
whose mechanisms are less clear. Such reactions include cell-mediated 
reactions that involve sensitised lymphocytes in tissues rather than anti-
bodies. In cell-mediated reactions, the onset of symptoms occurs more 
than 8 hours after ingestion of the offending food (FAO/WHO, 2001). 
It is not realistic to strive for absolute absence of risk for allergenicity. 
Instead, the general point of view is that the aim should be to ensure that a 
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novel food is at least as safe as its traditional counterpart, that food it will 
substitute in the diet. With this in mind, the objective with regard to aller-
genicity is to establish whether the novel food has an increased potential 
to induce sensitisation or to elicit allergic reactions than the food product 
it is compared to (Kimber and Dearman, 2002). Recommendation for 
labelling should be part of the consideration for reducing the risk. 
Food allergies are caused by a wide variety of foods of which the most 
important plant products are peanuts, soybeans, wheat and tree nuts. Al-
lergic reactions to fresh fruits and vegetables may also be expressed as an 
oral allergy syndrome (OAS). Symptoms of OAS are typically mild, and 
mostly confined to the oropharyngeal region. Some of the most signifi-
cant allergens from foods giving rise to OAS are unstable to heating and 
digestion. However, OAS in patients allergic to fruits and vegetables 
may, in some individuals, be followed by a systemic reaction 
(FAO/WHO, 2001). 
Novel food items may give rise to cross-reactivity to well-known food 
or pollen allergens. Such cross-reactions between new and well-known 
allergens can be studied by various methods: serological methods, skin 
prick tests, or by open challenge or double blind placebo controlled food 
challenge of allergic patients as was done with the nangai nut in the stud-
ies by Sten et al. (2002) and Fremont et al. (2001). 
In the rare cases when the amino acid sequence of proteins in novel 
foods are known, these sequences could be tested by bioinformatic meth-
ods to predict whether the protein is likely to be an allergen or not (Codex 
Alimentarius 2004). As none of the test methods available today is able to 
predict whether a protein is an allergen or not in the absence of the amino 
acid sequence, which is often the case for proteins in novel foods, there is 
a growing consensus that an appropriate validated animal model for char-
acterisation of allergenic potential is needed (FAO/WHO, 2001; König et 
al., 2004). At present animal models for predicting and characterising 
(protein) allergenicity are based upon assessment of induced antibody 
responses and/or the frequency of responders in the test groups. A con-
tinued research into the immunobiology of protein allergy with particular 
emphasis on the identification of molecular markers that can be used to 
distinguish protein allergens from non-sensitising proteins is required 
(König et al., 2004). The most appropriate animal models for allergenic-
ity available should be evaluated fully with a range of sensitising (weak 
and strong) and non-sensitising proteins so that their sensitivity and selec-
tivity can be assessed (König et al., 2004). 
7.6 New ”omics” methods 
Although many issues remain to be resolved and significant challenges 
lie ahead, it is expected that information obtained from genomics, tran-
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scriptomics, proteomics, and in particular metabolomics will be ex-
tremely useful in the identification, characterisation and profiling of the 
novel food itself as well as the plant as the source for the novel food. 
It can also be predicted that particularly metabolomics will have a sig-
nificant impact on the case-by-case approach to be taken in toxicology in 
the future. One can predict that the information gathered from experi-
ments using these technologies will form the basis for improved methods 
to assess the impact of chemicals on human health (Eisenbrand et al., 
2002) but this is an issue with implications much broader than just safety 
testing of novel plant foods. 
7.7 Human data 
Human experience, but normally not formal human scientific studies, is 
an essential part of the data collection in the history of use. The human 
experience on the intake of a certain food in a region different from the 
one, which has deemed the food to be a novel food, is normally just an 
empirical observation that the food in question has been eaten in this and 
this way for generations in that region. It will normally be coupled with 
information on how it is prepared, how it is eaten and how much, and 
whether the food in question has had any special claims linked to it. This 
kind of information is not following the rules for the performance of sci-
entific studies.  
There is no doubt that clinical studies in humans as well as epidemiol-
ogical data from retrospective and prospective human studies are likely to 
achieve a much greater role in assessment of the safety of novel foods 
than in other areas of safety testing.  Provided the in vivo animal studies 
demonstrate no adverse effects, human studies should be considered in 
order to confirm the absence of metabolic and physiological disturbances.  
A greater emphasis could be placed on availability of toxicokinetic stud-
ies to complement animal data. Additional mechanistic studies may be 
appropriate to investigate unexpected adverse effects. Whether specific 
subgroups of a population might be more sensitive to a potential hazard 
associated with a food might be studied in more details. More susceptible 
subgroups of a healthy population to certain risks often include infants, 
pregnant women, nursing mothers, and possibly the elderly. In many 
cases such studies can be performed without ethical concerns in regions 
where the food in question is already eaten and therefore not considered 
novel. 
Studies in humans should not form a routine part of the premarket 
safety assessment but they can contribute to it by providing confirmation 
of nutritional quality and the absence of adverse effects, which has been 
ruled out by previous considerations. Population studies carried out post-
launch in the target group of the general population (i.e. after the satisfac-
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tory completion of a safety assessment) may be helpful in providing con-
firmation of anticipated usage patterns and exposure levels. Human stud-
ies may also be used to examine bioavailability or human metabolism 
when the safety of a compound is known. For novel plant foods already 
eaten by humans somewhere, there will be no ethical constrains about 
performing the relevant human studies in such places. 
7.8 Nutritional aspects 
An evaluation of the nutritional characteristics of a novel food is an im-
portant component of the assessment process. The novel food should be 
evaluated from the perspective of its likely impact on the human diet to 
provide assurance that its introduction into the food chain will not cause 
adverse effects through nutritional inadequacy or excess. A basis for this 
evaluation may be provided by the information embedded in the history 
of use or it may be a combination of analytical data, claims or recom-
mendations intended for the marketing of the novel food and specifically 
designed human studies (see the section above). 
Key components of novel foods are in most cases nutrients in the par-
ticular food that may have a substantial nutritional impact on the con-
sumer. These constituents may be macro-nutrients (fats, proteins, carbo-
hydrates) or micro-nutrients (minerals and vitamins) (König et al., 2004). 
Novel foods may also contain anti-nutrients that inhibit or block path-
ways in the human metabolism, or impair digestion. Anti-nutrients may 
reduce nutrient utilisation, typically proteins, vitamins, or minerals, the-
reby decreasing the nutritive value of foods (König et al., 2004). 
7.9 Exposure assessment 
The exposure assessment of novel fruits and vegetables (as of any other 
novel food) should be undertaken to ensure an adequate Margin-of-
Exposure for users under the intended conditions of use.  
The intended or anticipated use of the exotic fruit or vegetable will 
provide information of absolute necessity for the assessment of whether 
the use will be safe or constitute a risk. It is of great importance for the 
outcome of the risk characterisation whether the novel food is intended or 
anticipated to be used only a few times throughout a lifetime or is it fore-
seen to be consumed in kilos per month. Often the sales arguments for the 
novel food and its price will tell if the novel food mainly preserves a 
good health or prevent chronic diseases in smaller dosages, is a new in-
teresting spice for food preparation, or it really is meant to replace a ma-
jor traditional food component, and thereby the volume to be sold. Whilst 
experience from the region from which the exotic fruit or vegetable ori-
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gins surely can provide helpful information, consumption patterns must 
be considered in the local context of the novel use proposed (Howlett et 
al., 2003). A food traditionally consumed only occasionally or exclu-
sively in combination with another material may cause problems when 
consumed in larger quantities or in a different combination (Howlett et 
al., 2003). 
The exposure assessment should also consider the appropriate ways of 
preparing and cooking the novel plant food. Some are to be eaten raw, 
some are to be milled to flour and go through baking processes, some are 
to be peeled and cooked, some are to be extracted, treated with acids or 
bases, dried and fried. All these processes greatly influence the contents 
and digestive availability of   inherent toxicants, macro- and micronutri-
ents of the individual novel food as assessed in the hazard characterisa-
tion. 
The primary objective of a food exposure assessment is to estimate the 
aggregate intake levels of the particular food or food constituent. This 
includes the determination of estimated daily intake and the theoretical 
maximum daily per capita intake (König et al., 2004). Exposure assess-
ments to specific foods may often lack precision because of a wide inter-
individual variation in food consumption within and across different po-
pulations. In consequence, it is important to gather information on food 
consumption both at the population level (per capita intake) and at the 
individual level.  
Furthermore, estimates should take into account variation amongst 
demographic subgroups of a population. Thus, it may be necessary to 
stratify dietary intake assessments of specific foods according to age, 
gender, socio-economic status, location, and ethnic origin depending on 
the outcome of the human studies on the novel food in question.  
New probabilistic tools allow a better and more realistic estimation of 
the likelihood of extreme exposures. 
7.10 Risk characterization and safety 
The risk characterisation is based upon the outcome of the hazard charac-
terisation and the exposure assessment. It does assess the safety and nutri-
tional properties of the defined plant food characterised by its botanical 
origin and chemical composition. The NNT recommends that the risk 
characterisation or – more correctly – the safety of the individual novel 
food is defined by its Margin-of-Exposure, which is calculated from the 
estimated daily safe intake divided by the likely human daily exposure. 
This value can then be used by the risk managers to guide the further 
decisions on the use of the novel plant food in the general food supply, 
and – if properly indicated at the food – by the individual consumer to 
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guide his/her choice for proper food that meets the individual expecta-
tions and needs. 
7.11Conclusions on tools applicable for premarket 
analysis  
The instruments and the concepts in the toolbox are not new but taken 
over from the fields of chemical safety and nutritional assessment to the 
field of whole food assessment. Some of them are already in the process 
of being readjusted and refined for the use in the safety assessment of 
novel foods.  
For the assessment of the safety of novel plant foods the most impor-
tant instruments prioritised by the NNT right now are the precise charac-
terisation of the plant food based upon the botanical characterisation and 
the chemical characterisation as well as its history of use, mainly based 
on the development and combined use of the proposed global list, re-
gional/local lists and ethnobotanical lists based upon quality assessed 
data on exposure and safety. Today such lists only exist to a very limited 
extent, and the data supporting the existing ones is often of uncertain 
origin with limited quality assurance linked to it. This is a major obstacle 
to the global trade with novel plant foods because the information from 
trustworthy lists in many cases will be sufficient to establish the history 
of safe use as guidance for the hazard characterization in a region where 
the food has not been eaten before. If the botanical characterisation and 
the chemical characterisation are well defined and the history of safe use 
can be established by the competent authorities, there may be no need to 
request animal studies and/or human studies in such a case.  
The section on animal studies concludes that well planned and well 
performed animal studies with strong focus on the design of the test diet 
are able to act as an efficient biological filter in the premarket situation 
for genuine novel foods. Clinical studies and formal epidemiological 
studies in humans are relevant as follow-up of the premarket situation, 
when a history of safe use cannot be established based upon available 
data and when the safety established in in-vivo studies diminishes the 
ethical barrier for doing human studies. 
 

 8. A plea for a continued 
interactive exchange of concepts 
and ideas between management 
and science in this field 
Plant foods that are traditional in one country or region may be novel in 
another country or region. The EU legislation makes it necessary to dis-
tinguish between the traditional plant foods on one side and the novel 
plant foods on the other side, because the novel plant foods according to 
the EU legislation need to go through a premarket assessment procedure. 
Since the EU legislation is pretty new, from 1997, the legal and scientific 
instruments for this process are not fully developed yet, and an interactive 
exchange of concepts and ideas between management and science is ur-
gently needed. 
On this background the present report has developed a proposal for a 
set of criteria for determining if a plant food is traditional or novel and a 
proposal for an approach for the safety assessment of such plant foods 
with no or limited documented history of safe consumption as presented 
in the preceding sections.  
During the development of these proposals a number of issues has un-
derlined the need for continuation of the interactive process between sci-
ence and management. As discussed below, there are still many unique, 
unripe concepts in the process, which need attention both from the scien-
tific and managerial angle, and many new instruments still need to be 
developed and refined in science and management to make the process a 
success for all. 
Chapter 2 presents the regulations of novel food in Canada, Austra-
lia/New Zealand and Europe where the exotic fruit and vegetables may be 
included in the respective definitions. Although these regulations make 
sense in their purpose to protect consumers against new foods with poten-
tial adverse effects, they all have the same inherent problem, namely that 
there in the practical execution of the legislation is quite a room for the 
individual interpretation of the term “novel” and for the case-by-case 
decision on whether or not a plant food fall under the legislation. 
From the historical experience presented in chapter 3 and examples on 
past and present introduction of plant foods in the market given in chapter 
4, it is clear that on one side we have evidence that traditional plant food 
products might have adverse effects on human health but on the other 
side this problem seems to be manageable taking into account both the 
84 Risk Assessment and Risk Management of novel Foods 
high number of traditional plant food products already on the market and 
the high number of novel plant food products already introduced. How-
ever both the high speed by which new foods can be introduced on the 
market today and the high expectations from the consumers about high 
quality of their food, has resulted in the political demand for regulation. 
High quality in this respect encompasses acceptable assurances about 
safety (including absence of allergenic potential), well established nutri-
tional and health promotional properties of the novel plant food as part of 
the overall diet as well as qualified guidance on proper use of the novel 
plant food explaining preparation and cooking procedures and honouring 
its new taste and flavour. An argument for not being too restrictive in the 
regulation of exotic fruits and vegetables is the fact that in contrast to e.g. 
food additives these new products as long as they are in their original 
shape as fruits and vegetables usually are very visible for the consumers, 
so they on the basis of the available information can make an informed 
choice of their own. 
 
A regulation with an approval procedure for plants for food use presents a 
lot of challenges: 
 
• The present regulation is based on terms like “novel food”, “history 
of safe use”, “insufficient knowledge”, “use in significant degree” 
etc. which in many cases are ill-defined and cause doubt about what 
should be approved and what should not. 
• One basic problem with the sentence “regulation of novel food 
should be focusing on the food plants with insufficient knowledge to 
enable safe use” (formulation from the Australia/New Zealand 
guidelines) is that - although it makes sense from a scientific point of 
view - “insufficient knowledge” is not easily or not clearly defined. 
We may easily end up in a situation, where every food plant and its 
food products may need to be evaluated by the authorities for their 
safety. Therefore one of the first tasks is to clarify the extent of the 
evaluation and the approval procedure from a management point of 
view. 
• It is normally recommended that the evaluation and approval take the 
botanical plant species as a starting point rather than the trivial trade 
name for the food such as kiwi or beans. However a plant species 
may contain many different varieties that need to be considered on 
their own. 
• For many plant foods defined as novel in a region, the plant food is 
already common in another region, where it as an additional 
complication may be derived from different plant varieties due to 
years of traditional breeding like it is the case for the kiwi. In 
considering its history of use and or its history of safe use, the size of 
the “window” for the assessment needs to be defined taking into 
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account which varieties of the plant species, if not all, are to be 
covered by the approval process. The distinction between food from 
highly bred varieties of a plant species and foods from the wild 
relatives might be essential in defining the novelty and carrying out 
the safety assessment. 
• Traditional breeding, including the use of techniques such as crossing 
and chemically or physically induced mutation combined with 
selection pressure, performed after an approval may lead to 
considerable changes in the composition of the food from the plant. 
Here it is important to define the “window” for which the approval is 
valid. In cases where certain key components such as toxic 
substances or vitamins have been identified in the safety assessment 
process, the term for the approval could be that these key components 
in the food should not be outside certain defined limits. For other 
cases the window for approval might be broader and give room for 
traditional breeding without any specified limits. In this case the plant 
that is the source of the approved novel food can be regulated as any 
other traditional bred plant used for food in the future. 
• History of safe use is an important criterion that may lead to approval 
of a food from a plant without further investigation. An attempt to 
define when history of safe use is fulfilled from a scientific view 
might easily end up with so high demands for scientific 
documentation that it is never readily obtainable even for well-known 
plant foods. Only few plant foods will have a history of safe use 
based on hard scientific evidence such as epidemiological 
surveillance. Premarket approval of novel plant foods may therefore 
need to apply a less scientific stringent procedure as the Canadian 
one (see page 11-12), where the case is qualified for assessment when 
history of use over several generations (i.e. 100 years) from other 
regions is evident and adverse effects, preparation for consumption, 
cultivation or harvesting, amounts likely to be consumed and normal 
composition are reported. 
• Some of the novel foods are intended for marketing with arguments 
supposed to support their sale. In some cases these arguments are 
claims for keeping a good health and prevent chronic diseases, in 
other cases the claims intend to cure diseases. In the latter situation 
the borderline to medicine may be rather thin, and therefore the 
intension to market such a product as a novel food rather than a 
medicine should be carefully considered as part of the approval 
procedure. 
 
Considering the nature of the issues raised above, the NNT early on con-
cluded that most of these issues carry a strong management component 
with a number of societal values attached to them. These issues are ad-
dressed in the 2-step management procedure described in chapter 6 with 
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determination of the novelty of the plant food as part of the establishment 
of a risk profile and with the establishment of a risk assessment policy for 
the conduct of the scientific risk assessment. The conclusions, which can 
be taken at each step, are highly depending on the scientific input into the 
process, including the scientific tools available for the safety evaluation 
presented in chapter 7.  
Most of these tools are also well known from other areas and widely 
discussed in connection with the safety assessment of food additives, 
pesticides, novel foods in general and foods from genetically modified 
plants. Therefore the discussion of those in chapter 7 and here does not 
go in every detail. 
 
The new concepts and principles for risk assessment and risk manage-
ment of novel plant foods introduced in this report are: 
 
• The 2-step management procedure for establishing the novelty and 
for committing resources for safety assessment, and  
• The use of a worldwide net of global, regional, local and 
ethnobotanical lists of food plants to guide the decision on novelty at 
the first step and to enable the safety assessment at the second step. 
 
At the first step of the 2-step management procedure the management 
establishes a risk profile with the input from stakeholders, scientists in the 
field and consumer representatives taking into account the product itself, 
information on expected intake, history of use, values at risk, e.g. human 
health, economy, other potential consequences, consumer perception of 
risks and benefits, and societal distribution of risks and benefits. The 
plant lists discussed below are an integrated element of the history of use. 
The discussions at this step lead to the conclusion whether the plant food 
under consideration is traditional at the regional level or local level or a 
traditional ethnic food in the area, or actually a novel plant food, which 
needs a safety assessment according to the regulation.  
At the second step of the 2-step management procedure the manage-
ment decides on the general risk assessment policy for plant food defined 
as novel foods at the first step. Risk assessment policy in this context 
means that the authorities based upon scientific advice and based upon an 
overall societal value judgment of pros et cons define the extent and se-
quence of the scientific data which should form the basic mandatory de-
mand for data to be made available for the scientific risk assessors in the 
premarket assessment phase. It is the authorities (= the management) who 
need to take the societal responsibility for the decision on availability of 
data for the assessment, since the resources to create the data cannot be 
committed by the scientists anyway, and since the scientific imagination 
of scientists for further request of scientific data is unlimited both due to 
their scientific wish to improve the assessment but also due to their pro-
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fessional desire to be able to take full scientific responsibility for the reli-
ability of the safety assessment. In practice the resources for creating the 
basic scientific data may need to come from the applicant, but it depends 
on the formulation of the regulation in the different countries/regions. In 
the end the outcome of the risk assessments in terms of sensitivity, speci-
ficity, and the resulting predictability is totally dependent on the initially 
decided, managerial risk assessment policy. 
For a smooth introduction of the so-called exotic fruits and vegetables 
from one region to another, the NNT recommends to use the “history of 
use”-concept as the core ingredient of the premarket submission. To the 
extent that the data submitted by the applicant can support the claim that 
a product has a history of safe use, the submission is accepted and no 
further data requested at this point. The NNT finds the Canadian ap-
proach quoted on page 11 excellent to guide the development of a general 
framework for both the global, regional and local risk assessment policies 
for novel plant foods. 
To support and ease the availability of the standardised and high qual-
ity “history of use” data for the premarket submissions, the NNT recom-
mends the development of a worldwide set of lists with recognised food 
plants covering the global, regional and local levels world-wide. The data 
given for each plant on the individual list should be identical to the data 
establishing the history of safe use of the fruits, roots or other plant tis-
sues as human food in that region or geographical area, the list is cover-
ing. When a plant food from a plant already on one regional list is to be 
introduced as a novel plant food in another region, the data documenting 
its safe use in the first region can be used both for the submission by the 
applicant in the second region and by the authorities and their experts in 
that region. It is clear that the lists have to build on reliable, high quality 
information and exactly referenced sources in order to make it possible 
for the scientific assessors to perform a proper safety assessment. 
Such lists do not exist at the present time, but each of the lists pre-
sented in Annex 2 and 3 give some hints regarding the wider perspectives 
of the concept suggested by the NNT.  The list modified from FAO in 
Annex 2 represents plants that are commercialised and is based on pro-
duction figures. This may cause some bias due to differences in use (e.g. 
as spices or for nutrition/energy), differences in the relation between pro-
duction and actual intake. Not all countries can give exact information on 
the commercial production, and the production from plants grown in ho-
me gardens might be underestimated. However it is expected that the 
plants (or plants products) on the FAO list all have a history of safe use as 
food if used in ways and levels well established in the worldwide food 
intake. 
Each regional list should contain (at best) those plant food items that 
are commonly used in that region and therefore in general have a long 
history of use and at least the potential for providing sufficient data to 
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fulfil the criteria for having a history of safe use, data which in turn may 
facilitate the introduction of such plant foods to regions where they have 
not been eaten before. The modified NETTOX list in Annex 3 covering 
about 300 plants used as food sources in the EU area in 1997 is probably 
the best example of a regional/local plant list available at present. The 
NETTOX list with all its background data (not presented in details in this 
report) is the one coming closest to the type of list, which is in the mind 
of the NNT. In chapter 5 three examples of ethnobotanical surveys, which 
may be turned into ethnobotanical lists, are presented. They all contain 
candidates for types of plant foods indefinitely novel in EU. 
Looking at the plant potential for introduction of novel plant foods, 
e.g. in Europe, there are over 1100 edible fruits recognized for food use 
in South America, 782 species of edible plants in Peru alone, and up to 
7000 other plant species used in the human food supply around in the 
world as explained in chapter 5. The 101 plant species on the NUS list in 
Annex 1 gives also some hints in that direction, although many of the 
plants are not to be considered novel (48 of the plants are on the NET-
TOX list). It is stated on the web site of IPGRI that the intention of the 
NUS list is to draw attention to plants with a potential to securing food 
and income in some poor, rural communities. However, it can be ex-
pected that many of these potential novel food plants in some regions 
with few starvation problems will fall into the category of plant foods 
being sold based on their claims for health promoting capabilities. Such 
plant food products may trigger considerations that the scientific bases 
for such a marketing procedure should be documented in order to assure 
against negative effects of over-use. Requirement for an appropriate la-
belling could in some cases be needed to solve some of the adverse health 
issues that the introduction of such plant foods might raise.  
The paradigm for the safety assessment of novel plant foods and novel 
plant food ingredients with all types of data sources is presented in Figure 
2 at page 34. Based upon the discussion in this chapter it is clear that in 
the opinion of the NNT the well described history of use possibly picked 
directly from one of the food plant lists will be sufficient to establish 
history of safe use in another region. Therefore new studies (chemical 
studies, animal studies, human studies, exposure studies) beyond those 
already cited in the history of use may not be needed in the premarket 
situation for the exotic fruits and vegetables. Of course such studies will 
be needed, if the cited history of use cannot lead to the establishment of 
history of safe use due to shortcomings in the characterization of the plant 
species, in the compositional data and historical evidence of food use, due 
to the nature and severity of possible adverse effects and the character of 
physiological effects, due to insecure safety consequences of the cultiva-
tion, harvesting, processing and preparation methods, and/or due to the 
information regarding possible amounts of the novel plant food to be 
eaten. A similar situation with a need for basic chemical studies, animal 
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studies, human studies and exposure studies exists if the novel plant food 
is derived from a not traditionally eaten part a traditional food plant, or if 
the novel plant food is derived from a plant, which never has been the 
source of human food anywhere. 
This report and the recommendations of this report only address the 
novelty and safety of human foods derived from plants. It is to be fore-
seen that similar considerations and approximately similar recommenda-
tions could – or should - be developed to address the novelty and safety 
of mushrooms where only few species out of several thousands in each 
region are edible for humans. 
This report on exotic fruits and vegetables as novel and safe sources 
for food gives “the-state-of-the-art” in an area of the food safety arena, 
where there is still very little experience.  
Each definitive conclusion regarding novelty and safety of these plant 
foods needs to be taken with caution, since all perspectives need to be 
taken into account and no one forgotten, because these conclusions in the 
end have great consequences for the global food supply and the global 
trade with food commodities and may change the perspectives for the 
physical and cultural survival of large and small communities.  
Therefore the heading of this chapter announces a plea for a continued 
interactive exchange of concepts and ideas between management and 
science in this field – both at the local, regional and global levels and 
between those levels. 
 
 9. Overall conclusions and 
recommendations. 
The European Union, Australia/New Zealand and Canada have intro-
duced a pre-market notification or assessment and approval of novel 
foods in their regulation, and the managerial and scientific instruments 
for the enforcement of this regulation are under development.  
A special area in this respect is the area of plant foods, where mutually 
accepted concepts and principles for risk assessment and risk manage-
ment of novel plant foods are urgently needed to ensure a sufficient 
global production of safe and nutritious food and a smooth international 
trade based on mutual acceptance of this food.  
This report of the NNT analyses this regulatory situation and identifies 
the definitions of novelty and safety in relation to plant foods as the main 
challenges both globally, regionally and locally. The outcome of this 
analysis is that the NNT recommends the introduction of: 
 
• A 2-step management procedure, first to establish the novelty and 
secondly to define and commit resources for the safety assessment, 
and  
• A worldwide net of global, regional, local and ethnobotanical lists of 
food plants to guide the decision on novelty at the first step and to 
enable the safety assessment at the second step.     
 
At the first step of the 2-step management procedure the management 
establishes a risk profile for the plant food with the input from stake-
holders, scientists in the field and consumer representatives taking into 
account the product itself, information on expected intake, history of use, 
values at risk, e.g. human health, economy, other potential consequences, 
consumer perception of risks and benefits, and societal distribution of 
risks and benefits. The plant lists discussed below are an integrated ele-
ment of the history of use. The discussions at this step should lead to the 
conclusion whether the plant food under consideration is traditional at the 
regional level, local level or a traditional ethnic food in the area, or actu-
ally a novel plant food, which needs a safety assessment according to the 
regulation.  
At the second step of the 2-step management procedure recommended 
above the management decides on the general risk assessment policy for 
all plant foods defined as novel foods at the first step. Risk assessment 
policy in this context means that the authorities, based upon scientific 
advice and based upon an overall societal value judgment of pros et cons, 
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define the extent and sequence of the scientific data which should as a 
basic mandatory demand be made available for the scientific risk asses-
sors in the premarket assessment phase. In the end, the outcome of the 
risk assessments in terms of sensitivity, specificity, and the resulting pre-
dictability is totally dependent on the initially decided, managerial risk 
assessment policy. 
For a smooth introduction of the so-called exotic fruits and vegetables 
from one region to another the NNT recommends to use the “history of 
use”-concept as the core ingredient of the premarket submission. To the 
extent that the data submitted by the applicant can support the claim that 
a product has a history of safe use, the submission is accepted and no 
further data requested at this point. The NNT finds the Canadian ap-
proach quoted on page 11 excellent to guide the development of a general 
framework for both the global, regional and local risk assessment policies 
for novel plant foods. 
To support and ease the availability of the standardised and high qual-
ity “history of use” data for the premarket submissions the NNT recom-
mends the development of a set of lists with food plants recognized either 
at the global level, at different regional levels or local levels or known as 
ethnobotanical food plants in different places. The individual lists should 
reflect the use of plant foods in the region, at the local level or the ethno-
botanical setting, where they are developed. When all of them are avail-
able, they should create a complete global picture of the use of plant 
foods. The NNT expects that the combined use of data from all these lists 
will facilitate the mutual acceptance of safety and benefits of plant foods 
and plant food ingredients across political, economical and cultural bor-
ders. It is clear that the lists need to build on reliable, high quality infor-
mation and proper reference sources in order to meet the acceptance of 
critical scientific assessors. The NNT concludes on this basis that the well 
described history of use picked directly from a well developed food plant 
lists in one region will be sufficient to establish history of safe use in 
another region. Therefore new studies like chemical studies, animal stud-
ies, human studies and exposure studies beyond those already cited in the 
history of use may be unnecessary in the premarket situation for the ex-
otic fruits and vegetables. Of course such studies will be needed, if the 
cited history of use cannot lead to the establishment of history of safe use, 
if the novel plant food is derived from a not traditionally eaten part of a 
traditional food plant, or if the novel plant food is derived from a plant, 
which never has been the source of human food any place. 
This report describes “the-state-of-the-art” and gives recommenda-
tions in an area of the food safety arena, where only few concepts and 
ideas are fixed yet by administrative practices and scientific “rules-of-
thumb”. Each definitive conclusion needs to be taken with caution, since 
all potential consequences need to be taken into account and no one for-
gotten, because these conclusions in the end have great perspectives for 
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the global food supply and the global trade with food commodities and 
may change the basis for the physical and cultural survival of large and 
small communities.  
Therefore the NNT strongly recommends continued interactive ex-
changes of concepts and ideas between management and science in this 
field both at the local, regional and global levels and between those lev-
els. 
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Annex 1. Examples of NUS in 
the Regions 
From http://www.ipgri.cgiar.org/nus/home.htm . The column “Americas” 
contains no marks but instead the page contain a link to a inventory list of 
native fruits from America (http://www.ciat.cgiar.org/ipgri/fruits_from_ 
americas/frutales/fruits_from_america.htm ). 
 
Botanical name Common name Europe Asia 
Pacific 
Oceania 
Central 
West 
Asia 
North 
Africa 
Sub 
Saharan 
Africa 
Americas 
 
Cereals and pseudocereals     
Brachiaria deflexa guinea millet    x  
Digitaria exilis fonio    x  
Eleusine coracana finger millet  x    
Fagopyrum spp. buckwheat x x    
Pennisetum glaucum pennisetum    x  
Secale cereale rye x  x   
Setaria italica foxtail millet  x    
Stipa lagascae stipa   x   
Triticum monococcum/ dic./ spelt hulled wheat x  x   
Legumes     
Kerstingiella geocarpa Kersting's groundnut    x  
Lathyrus spp. grass pea  x    
Lupinus spp. lupin x  x   
Macrotyloma uniflorum horse gram  x    
Mucuna spp. velvet bean    x  
Phaseolus angularis adzuki bean  x    
Phsophocarpus tetragonolobus winged bean  x    
Plectranthus esculentus coffee potato    x  
Sphenostylis stenocarpa African yam bean    x  
Trigonella foenum graecum fenum-greek   x   
Tylosema esculentum marama bean    x  
Vigna subterranea bambarra groundnut    x  
Vegetables     
Abelmoshus esculentum okra  x    
Allium spp. shallot, chives, leek, 
onion, garlic 
x     
Amaranthus spp. amaranth    x  
Brassica spp. brassicas x  x   
Capparis spp. caper x  x   
Chicorium spp. chicory x  x   
Chorchorus olitorius chorchorus    x  
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Citrullus lanatus water melon    x  
Cleome gynandra cat's whiskers    x  
Cucurbita moschata pumpkin  x    
Cynara cardunculus cardon x     
Eruca/ Diplotaxis spp. rocket x     
Hibiscus sabdariffa roselle    x  
Malva spp. mallow x  x   
Scolymus spp. Spanish oyster/ 
golden thistle 
  x   
Sechium edule chayote  x    
Solanum melongena egg plant  x    
Solanum nigrum black nightshade  x    
Valerianlella locusta corn salad x     
Fruits and nuts     
Adansonia digitata baobab    x  
Artocarpus spp. bread fruit, jackfruit  x    
Butyrospermum kirkii shea butter tree    x  
Carissa edulis natal plum    x  
Ceratonia siliqua carob   x   
Cordeaxia edulis yeeb nut    x  
Cydonia oblonga quince   x   
Durio zibethinus durian  x x   
Dyosphyros kaki Japanese parsimon  x    
Ficus carica fig   x   
Garcinia mangostana mangosteen  x    
Irvingia gabonensis dika nuts    x  
Litchi chinensis litchi  x    
Metroxylon sagu sago palm  x    
Nephelium lappaceum rambutan  x    
Phoenix dactylifera date palm   x   
Physalis alkekengi Chinese lantern x     
Pistacia vera pistachio   x   
Plyllanthus spp. Indian gooseberry  x    
Pomegranate Punica granatum   x   
Prunus spp. wild Prunus spp.   x   
Schlerocarrya birrea marula    x  
Tamarindus indica tamarind  x    
Treculia africana African breadfruit    x  
Zizyphus spp. jujube  x x   
Beverages, stimulants, medicinal, aromatic     
Artemisia spp. absinthe   x   
Cola spp. Cola nut    x  
Coriander spp. coriander  x x   
Crocus sativus saffron x  x   
Glycyrrhiza glabra liquorice x     
Origanum spp. oregano   x   
Raphia spp. wine palm    x  
Rhaphanus sativus horse radish x     
Rosmarunus spp. rosmarin   x   
Thymus spp. thyme   x   
Zingiber officinale ginger  x    
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Industrial     
Carthamus spp. safflower  x x   
Dioscorea zingiberensis yam  x    
Guizotia abyssinica niger  x    
Laurus nobilis laurel x  x   
Rhus coriaria sumac   x   
Sesamum indicum sesame  x x x  
Stipa tenacissima esparto   x   
Vetiveria zizanioides vetiver grass      
Forage and browse     
Atriplex halymus saltbush   x   
Dactylis glomerata cock's foot   x   
Hedisarum spp. sulla x  x   
Lathyrus spp. grass pea  x x x  
Leucaena leucocephala leucaena  x    
Panicum spp. panicum  x    
Salsola spp. thistle   x   
Forest trees     
Abies spp. fir x  x   
Acacia spp. acacia   x x  
Juniper spp. juniper x  x   
Pistacia spp. wild pistachio x  x   
Quercus spp. oak x  x   
Roots and Tubers     
Coleus dysentericus frafra potato    x  
Colocasia esculenta cocoyam  x  x  
Dioscorea spp. yam  x  x  
Pastinaca sativa parsnip x     
Sphenostylis stenocarpa African yam bean    x  
 
 Annex 2. Draft global list based 
on the FAO-list of global plant 
food production 
 Developed on the basis of: http://faostat.fao.org/faostat/collections?subset=agriculture 
 
  Item Megaton 
1 Sugar Cane 1.333.253 
2 Maize 638.043 
3 Rice, Paddy 589.126 
4 Wheat 556.349 
5 Potatoes 310.810 
6 Sugar Beets 233.487 
7 Soybeans 189.234 
8 Cassava 189.100 
9 Barley 141.503 
10 Sweet Potatoes 121.853 
11 Tomatoes 113.308 
12 Watermelons 91.790 
13 Bananas 69.286 
14 Cabbages 65.956 
15 Grapes 60.883 
16 Sorghum 59.584 
17 Apples 57.967 
18 Seed Cotton 56.097 
19 Coconuts 52.940 
20 Onions, Dry 52.547 
21 Yams 39.913 
22 Cucumbers and Gherkins 39.599 
23 Rapeseed 36.146 
24 Groundnuts in Shell 35.658 
25 Plantains 32.974 
26 Millet 29.806 
27 Eggplants 28.994 
28 Sunflower Seed 27.740 
29 
Cantaloupes & other 
Melons 26.749 
30 Oats 26.269 
31 Mangoes 25.563 
32 Carrots 23.321 
33 
Chillies & Peppers, 
Green 23.248 
34 
Tang. Mand. Clement. 
Satsuma 20.950 
35 Lettuce 20.810 
36 Beans, Dry 19.038 
37 Pears 17.191 
38 Olives 17.169 
39 Cauliflower 15.948 
40 Rye 14.851 
41 Peaches and Nectarines 14.788 
42 Pineapples 14.616 
43 Garlic 13.696 
44 Lemons and Limes 12.452 
45 Spinach 11.862 
46 Peas, Dry 10.248 
47 Triticale 10.245 
48 Plums 10.110 
49 Green Corn (Maize) 9.066 
50 Taro (Coco Yam) 8.939 
51 Peas, Green 8.914 
52 Coffee, Green 7.796 
53 Palm Kernels 7.503 
54 Chick-Peas 7.123 
55 Dates 6.749 
56 Papayas 6.342 
57 Asparagus 6.288 
58 Beans, Green 5.933 
59 Okra 4.940 
60 Grapefruit and Pomelos 4.697 
61 Broad Beans, Dry 4.033 
62 Cow Peas, Dry 3.722 
63 Cocoa Beans 3.257 
64 Tea 3.207 
65 Strawberries 3.199 
66 Lentils 3.093 
67 Pigeon Peas 3.053 
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68 Avocados 3.040 
69 Sesame Seed 2.942 
70 Apricots 2.529 
71 Pimento, Allspice 2.482 
72 Persimmons 2.430 
73 Linseed 2.091 
74 Cashew Nuts 2.034 
75 Buckwheat 2.008 
76 Cherries 1.872 
77 Almonds 1.679 
78 Cashewapple 1.671 
79 String Beans 1.625 
80 Lupins 1.593 
81 Walnuts 1.446 
82 Artichokes 1.171 
83 Figs 1.087 
84 Sour Cherries 1.055 
85 Broad Beans, Green 1.052 
 Annex 3. Draft regional plant list 
based on the NETTOX food plant 
list. 
This regional food plant list for EU is the NETTOX food plant list from 
1997 exempted the plants on the FAO list in Annex 2. 
 
English Latin Names 
  Acer saccharum Marsh.  
Alligator pepper, guinea grains  Aframomum melegueta (Rosc.) K. Schum.  
Lesser galangal  Alpinia officinarum Hance  
Dill  Anethum graveolens L.  
Angelica  Angelica archangelica L.  
Cherimoya  Annona cherimola Mill.  
Pond apple  Annona glabra L.  
Soursop  Annona muricata L.  
Bullock's heart  Annona reticulata L.   
Noble chamomile, roman chamomile  Anthemis nobilis L.  
Celery, celeriac  Apium graveolens L.  
Breadfruit, breadnut  Artocarpus communis J.R. et J.G.A. Foster  
Orache, garden orache  Atriplex hortensis L.   
Carambola, starfruit, caramba  Averrhoa carambola L.  
Malabar  spinach, Ceylon spinach, Indian 
spinach  Basella alba L.  
European barberry  Berberis vulgaris L.  
Chard, swiss chard, leaf beet, spinach beet  Beta vulgaris L. ssp. vulgaris var. cicla L.s.l.  
Borage  Borago officinalis L.  
Caraway  Carum carvi L.  
Coffee chicory  Cichorium intybus L. cv sativum  
Chinese cinnamon, Chinese cassia  Cinnamomum aromaticum Nees   
Batavia cinnamon, padang cassia  Cinnamomum burmanii Bl.  
Ceylon cinnamon  Cinnamomum zeylandicum Schaeff.  
King mandarin tree  Citrus nobilis L.   
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Spoon-wort, scurvy-grass  Cochlearia officinalis L.  
Coriander  Coriandrum sativum L.  
Cornelian cherry, cornel tree  Cornus mas L.   
Saffron, crocus  Crocus sativus L.  
Cumin, cummin  Cuminum cyminum L.  
Common turmerio, Turmeric plant, Indian 
saffron  Curcuma longa L.  
Zedoary  Curcuma zedoaria (Bergius) Rosc.  
Sere-grass, lemongrass, West Indian lemon-
grass   Cymbopogon citratus (D.C.) Stapf.  
Cardoon  Cynara cardunculus    
Earth almond, yellow nutsedge  Cyperus esculentus  
Water chestnut, matting reed, Chinese water 
chestnut  Eleocharis dulcis (Burm. F.) Trinius ex Henschel  
Cardamon plant, cluster  Elettaria cardamomum (L.) Maton  
Rocket salad  Eruca sativa Mill.  
Surinam cherry, Brazil cherry  Eugenia uniflora L.  
Marumikunquat, round kunquat    Fortunella japonica (Thumb.) Swingle  
Kunquat, kunquat maruoni   Fortunella margarita (Lour) S.  
Wild strawberry  Fragaria vesca L.  
Scarlet strawberry, Virginia strawberry  Fragaria virginiana Mill.   
Liquorice  Glycyrrhiza glabra L.  
Cotton  Gossypium Sp.  
Topinambur, Jerusalem artichoke  Helianthus tuberosus L.  
Roselle  Hibiscus sabdariffa L.  
Hyssop  Hyssopus officinalis L.  
Chinese anise, star anise tree  Illicium verum J.D. Hook  
Water Spinach  Ipomoea aquatica Forsk.  
Juniper  Juniperus communis L.  
Hyacinth bean, bonavist bean, lablab bean  Lablab purpureus (L.) Sweet  
Delicicus lactarius  Lactarius deliciosus Fr.  
Prickly lettuce  Lactuca serriola Turner L.  
Bottle gourd, calabash gourd  Lagenaria siceraria (Molina) Standl  
Chickling vetch, grasspea, kaasari  Lathyrus sativus L.  
Sweet bay, laurel, bay tree  Laurus nobilis L.  
Boletus  Leccinum scabrum Fr.   
Lovage, garden lovage  Levisticum officinale W. Koch  
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Lemon verbena  Lippia triphylla (L'Hér.) Kuntze  
Acerola  Malpighia punicifolia L.   
Sapodilla, chicle  Manilkara zapota (L.) van Royen   
Balm, lemon balm  Melissa officinalis L.   
Spearmint Mentha spicata L.  
Spearmint  Mentha spicata L. emend L.  
African cucumber, balsam epar, balsam apple  Momordica charantia L.  
Sweet basil, common basil  Ocimum basilicum L.  
Sweet majoram  Origanum majorana L.  
Wild marjoram, European oregano  Origanum vulgare L.   
Guaraná  Paullina cupana H.B.K.  
Chinese lantern, winter cherry  Physalis alkekengi L.   
Cape gooseberry  Physalis peruviana L.   
Allspice, Jamaica pepper  Pimenta dioica (L.) Merr.  
Anise  Pimpinella anisum L.   
Purslane  Portulaca oleracea L. ssp. sativa (Haw.) Celak.   
Cherry-plum tree, myrobalan-plum tree  Prunus cerasifera Ehrh.  
Japanese plum  Prunus salicina Lindl.  
Brasilian guava, Guinea guaava, guisaro  Psidium guineense  
Archil, orchil, angola weeb  Rorippa Nasturtium-aquaticum (L.) Hayeck.   
Dog rose, wild rose  Rosa canina L.  
Rosemary  Rosmarinus officinalis L.  
Cloudberry  Rubus chamaemorus L.   
Blackberry  Rubus fruticosus L.   
Raspberry  Rubus ideaus L.  
Sage  Salvia officinalis L.  
Brazilian peppertree  Schinus terebinthifolius Raddi  
Sesame, beniseed  Sesamum indicum L.  
Chinese artichoke, Japonese artichoke,   Stachys affinis Bunge   
Ringed boletus  Suillus luteus Fr.  
Clove tree  Syzygium aromaticum (L.) Merr. & L.M. Perry  
Rose apple, jambos  Syzygium jambos (L.) Alston  
Dandelion  Taraxacum officinale Weber  
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New Zealand spinach  Tetragonia tetragonioides (Pall.) Kuntze  
Wild thyme, creeping thyme  Thymus serpillum L.   
Garden thyme, common thyme  Thymus vulgaris L.  
Small-leaved lime tree, winter linden tree  Tilia cordata Mill.  
Large -leaved lime tree, summer linden   Tilia platophyllos Scop.  
Water chestnut, caltrops  Trapa natans L.  
African breadfruit  Treculia africana L.  
Fenugreek  Trigonella foenum-graecum L.  
Indian cress, garden nasturtium  Tropaeolum majus L.   
Truffle  Tuber melanosporum Vitt.  
Nettle, stinging nettle  Urtica dioica L.   
  Vaccinium uliginosum L.  
Cowberry  Vaccinium vitis-idaea L.  
Cornsalad, lamb's lettuce  Valerianella locusta (L.) Laterrade  
Adzuki bean  Vigna angularis (Willd.) Ohwi et Ohashi   
Black gram  Vigna mungo (L.) Hepper  
Chinese date  Ziziphus ziziphus L. Meikle  
 
